<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6357194</article-id><article-id pub-id-type="doi">10.3390/toxins11010034</article-id><article-id pub-id-type="publisher-id">toxins-11-00034</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Poulain</surname><given-names>Bernard</given-names></name><xref ref-type="aff" rid="af1-toxins-11-00034">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9305-8989</contrib-id><name><surname>Popoff</surname><given-names>Michel R.</given-names></name><xref ref-type="aff" rid="af2-toxins-11-00034">2</xref><xref rid="c1-toxins-11-00034" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-11-00034"><label>1</label>Institut des Neurosciences Cellulaires et Int&#x000e9;gratives, (INCI)-CNRS, UPR 3212 Strasbourg, France; <email>poulain@inci-cnrs.unistra.fr</email></aff><aff id="af2-toxins-11-00034"><label>2</label>Bacterial Toxins, Institut Pasteur, 75015 Paris, France</aff><author-notes><corresp id="c1-toxins-11-00034"><label>*</label>Correspondence: <email>mpopoff@pasteur.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2019</year></pub-date><volume>11</volume><issue>1</issue><elocation-id>34</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>09</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Botulinum neurotoxins (BoNTs) are the most lethal toxins among all bacterial, animal, plant and chemical poisonous compounds. Although a great effort has been made to understand their mode of action, some questions are still open. Why, and for what benefit, have environmental bacteria that accidentally interact with their host engineered so diverse and so specific toxins targeting one of the most specialized physiological processes, the neuroexocytosis of higher organisms? The extreme potency of BoNT does not result from only one hyperactive step, but in contrast to other potent lethal toxins, from multi-step activity. The cumulative effects of the different steps, each having a limited effect, make BoNTs the most potent lethal toxins. This is a unique mode of evolution of a toxic compound, the high potency of which results from multiple steps driven by unknown selection pressure, targeting one of the most critical physiological process of higher organisms.</p></abstract><kwd-group><kwd>botulinum neurotoxins</kwd><kwd><italic>Clostridium botulinum</italic></kwd><kwd>botulism</kwd><kwd>neuroexocytosis</kwd><kwd>SNARE proteins</kwd></kwd-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>Botulinum neurotoxins are the most lethal toxins, the extreme potency of which results from an accumulation of multiple steps. They are produced by environmental bacteria and show a large diversity indicating a complex evolution from an unknown origin.</p></notes></front><body><sec id="sec1-toxins-11-00034"><title>1. Introduction</title><p>Botulinum neurotoxins (BoNTs) are the most potent protein toxins among bacterial, animal, plant and chemical poisonous substances so far known, with a lethal parenteral dose for BoNT type A of about 0.2&#x02013;0.3 ng/kg in mice and 1 ng/kg in human [<xref rid="B1-toxins-11-00034" ref-type="bibr">1</xref>,<xref rid="B2-toxins-11-00034" ref-type="bibr">2</xref>]. A small amount of 30 ng is sufficient to induce botulism in human adults by the oral route [<xref rid="B3-toxins-11-00034" ref-type="bibr">3</xref>]. BoNTs are responsible for botulism, which is a rare but severe neurological disease characterized by flaccid paralysis, inhibition of secretion, and mild dysautonomia. Deciphering the poisoning process, how they disseminate in the host body, and what the different cellular steps of their mechanism of action are have revealed how highly sophisticated these nano-scale neurotropic weapons are. Several physiologically distinct bacteria produce closely related types of these deadly poisons. These pathogens are mainly environmental bacterial from soil, sediments, and occasionally the intestinal content of man and animals. Despite the fact that they have not developed a strategy to invade and survive in a vertebrate host, these bacteria have evolved to produce a potent toxin targeting specifically the neuroexocytosis machinery, which is designed to kill a host at a distance from the site where they replicate and grow. This is a very unusual property. Does this confer them some competitive advantage favoring the spreading of the neurotoxin genes among different bacterial species? The aim of this short review is to comment on the different fascinating aspects of these most potent toxins.</p></sec><sec id="sec2-toxins-11-00034"><title>2. Diversity of Botulinum Neurotoxins and Toxin Complexes</title><p>BoNTs are produced as single-chain proteins (~150 kDa, MW). Until one decade ago, only 7 BoNT toxinotypes (A to G), defined by neutralization with corresponding specific antibodies, were recognized. Then, a chimeric BoNT type FA or HA (also called BoNT/H) was identified in a bivalent <italic>C. botulinum</italic> Bh strain responsible for infant botulism [<xref rid="B4-toxins-11-00034" ref-type="bibr">4</xref>,<xref rid="B5-toxins-11-00034" ref-type="bibr">5</xref>,<xref rid="B6-toxins-11-00034" ref-type="bibr">6</xref>]. This discovery was followed by that of another putative novel type, called X, in a bivalent <italic>C. botulinum</italic> B strain, the toxicity of which remains to be determined [<xref rid="B7-toxins-11-00034" ref-type="bibr">7</xref>]. <italic>bont</italic> gene sequence comparisons have permitted the identification of a large, still increasing, number of subtypes for each toxinotype (globally more than 40) [<xref rid="B8-toxins-11-00034" ref-type="bibr">8</xref>]). For example, BoNT/A is subdivided into BoNT/A1 to BoNT/A8, BoNT/B into BoNT/B1 to BoNT/B8, BoNT/E into BoNT/E1 to BoNT/E12, and BoNT/F into BoNT/F1 to BoNT/F8 [<xref rid="B8-toxins-11-00034" ref-type="bibr">8</xref>]. Most often, a given toxigenic strain produces only one BoNT type and subtype. However, some rare strains, called bivalent or trivalent strains, synthesize two BoNT types such as Ba, Bf, Ab, Af (the lower-case letter meaning that the corresponding type is produced in a minor amount) [<xref rid="B8-toxins-11-00034" ref-type="bibr">8</xref>] (<xref rid="toxins-11-00034-t001" ref-type="table">Table 1</xref> and <xref rid="toxins-11-00034-t002" ref-type="table">Table 2</xref>).</p><p>All the various types of BoNT are subsequently processed by endogenous or host proteases into a heavy (Hc) and a light (Lc) chain, linked together by a disulfide bond. Moreover, they are co-synthetized with one conserved associated protein, NTNH (non-toxic non-hemagglutinin protein, 150 kDa), and several hemagglutinins (HAs) or proteins of unknown properties (OrfX). At the 3D structure level, NTNH looks very similar to BoNT, except that it is devoid of neurotoxic activity. The association of a BoNT molecule with a NTNH copy confers to BoNT a long-term stability, supporting a chaperone activity for NTNH [<xref rid="B9-toxins-11-00034" ref-type="bibr">9</xref>]. A large variety of multimeric complexes (referred to as &#x0201c;botulinum toxin complexes&#x0201d; or &#x0201c;progenitor toxins&#x0201d;) can be formed. Each of them contains only one copy of BoNT, which can be released upon the exposure of botulinum complex to neutral or mildly basic pH [<xref rid="B10-toxins-11-00034" ref-type="bibr">10</xref>].</p></sec><sec id="sec3-toxins-11-00034"><title>3. Diversity of BoNT-Producing Bacteria: <italic>Clostridia</italic>, et al.</title><p>To date, the production of BoNTs has been reported in Gram-positive, sporulating anaerobic bacteria belonging to the <italic>Clostridium</italic> genus. This is not surprising because among more than 200 <italic>Clostridium</italic> species, 15 produce very potent toxins, which are responsible for severe diseases in humans and animals. Since BoNT-producing bacteria share the same phenotype consisting of producing flaccid paralyzing neurotoxins, most of the neurotoxigenic clostridia have been named <italic>Clostridium botulinum</italic>, without consideration of their physiological heterogeneity. Based on phenotypic markers (e.g., proteolysis, lipolysis, carbohydrate utilization), 16 rRNA gene sequences, and a whole-genome sequence comparison, neurotoxigenic <italic>Clostridia</italic>-producing BoNT belongs to at least six groups (I to VI) corresponding to distinct bacterial species. The so-called <italic>C. botulinum</italic> strains of group I produce highly thermoresistant spores and grow between 10 &#x000b0;C and 37 &#x000b0;C, whereas strains of group II are non-proteolytic, have moderate thermoresistant spores, and grow and produce toxins at temperatures as low as 3.5 &#x000b0;C. <italic>C. botulinum</italic> C and D, mainly responsible for animal botulism, preferentially grow at higher temperature s(37&#x02013;40 &#x000b0;C) and are referred to as group III. <italic>C. argentinense</italic>, which produces BoNT/G, is the prototype of group IV. In addition, several other, albeit atypical, strains of <italic>Clostridium</italic> species are neurotoxigenic: certain <italic>C. baratii</italic> strains produce BoNT/F (referred to as BoNT/F7) and some <italic>C. butyricum</italic> strains synthesize BoNT/E (referred as BoNT/E4 and E5). They are assigned to groups V and VI, respectively, and show phenotypic properties related to those of the corresponding <italic>Clostridium</italic> species type strains [<xref rid="B11-toxins-11-00034" ref-type="bibr">11</xref>,<xref rid="B12-toxins-11-00034" ref-type="bibr">12</xref>]. Moreover, the neurotoxigenic strains of each group or species display a genetic variability. For example, multilocus sequence typing defines several phylogenetic clusters in each group [<xref rid="B13-toxins-11-00034" ref-type="bibr">13</xref>,<xref rid="B14-toxins-11-00034" ref-type="bibr">14</xref>,<xref rid="B15-toxins-11-00034" ref-type="bibr">15</xref>,<xref rid="B16-toxins-11-00034" ref-type="bibr">16</xref>,<xref rid="B17-toxins-11-00034" ref-type="bibr">17</xref>,<xref rid="B18-toxins-11-00034" ref-type="bibr">18</xref>].</p><p>Moreover, the screening of <italic>bont</italic> gene sequences in available genomic sequences in databases have revealed that <italic>bont</italic> sequences are not restricted to clostridia. Non-clostridial <italic>bont</italic> homologs have been identified in other anaerobes and aerobes. <italic>bont</italic>-like gene clusters have been identified in <italic>Weisella oryzae</italic> (referred as BoNT/I or BoNT/Wo), which is a Gram-positive, non-spore-forming, facultative anaerobe from fermented rice [<xref rid="B19-toxins-11-00034" ref-type="bibr">19</xref>], and in <italic>Chryseobacterium piperi</italic> (referred as BoNT/Cp1), which is a Gram-negative, non-spore-forming, strictly aerobic bacterium from the environment [<xref rid="B20-toxins-11-00034" ref-type="bibr">20</xref>,<xref rid="B21-toxins-11-00034" ref-type="bibr">21</xref>]. In addition, an <italic>Enterococcus faecium</italic> strain isolated from cow has been found containing a <italic>bont</italic>-related gene in an OrfX cluster that encodes for BoNT/En. This BoNT, also called BoNT/J, shares a 38.7% identity with BoNT/X and is more distantly related (23&#x02013;25% identity) to the other BoNTs and tetanus neurotoxin (TeNT) [<xref rid="B22-toxins-11-00034" ref-type="bibr">22</xref>,<xref rid="B23-toxins-11-00034" ref-type="bibr">23</xref>]. The production of functional BoNTs by these non-clostridial microorganisms has not yet been reported. However, the question of whether BoNTs should still be considered as only clostridial toxins is now open.</p></sec><sec id="sec4-toxins-11-00034"><title>4. Though Distinct, the BoNTs Cause Similar Diseases</title><p>Intoxication with one of the various BoNT types or subtypes causes a unique severe neurological disease: botulism [<xref rid="B24-toxins-11-00034" ref-type="bibr">24</xref>,<xref rid="B25-toxins-11-00034" ref-type="bibr">25</xref>]. Overall, the disease results from the inhibition of cholinergic neurotransmission in the peripheral part of the nervous system. In mammals, botulism is characterized by mild dysautonomia (including the inhibition of gland secretion) and prominent muscle fatigue or flaccid paralysis. In the most severe forms, respiratory distress occurs and may be fatal without treatment. The clinical manifestations of botulism may vary in a subtle manner within the different toxinotypes and even subtypes. For instance, dysautonomia is more marked after poisoning with BoNT/B than with BoNT/A [<xref rid="B24-toxins-11-00034" ref-type="bibr">24</xref>,<xref rid="B25-toxins-11-00034" ref-type="bibr">25</xref>]; type F botulism is also a severe form of botulism but with a shorter duration compared to type A botulism [<xref rid="B26-toxins-11-00034" ref-type="bibr">26</xref>].</p><p>Human foodborne botulism, subsequent to the ingestion of preformed BoNT in food, is common in many countries, such as in Europe. It is mainly caused by types A, B, E and more rarely F. Botulism can also result from <italic>C. botulinum</italic> intestinal colonization and subsequent local BoNT production in human infants (infant botulism is the main form in the US) and more rarely in adults with immature/altered microbiota. In addition, rarer forms have been reported such as after the colonization of a necrotizing wound, botulism by inhalation, and iatrogenic botulism. Large outbreaks of animal botulism have been reported in mammals (e.g., cattle, minks, ferrets, foxes), birds (e.g., waterfowl) due to intoxication by types C, D, dominantly. Fishes are also susceptible to the disease (types E, B, and C) [<xref rid="B12-toxins-11-00034" ref-type="bibr">12</xref>,<xref rid="B25-toxins-11-00034" ref-type="bibr">25</xref>,<xref rid="B27-toxins-11-00034" ref-type="bibr">27</xref>,<xref rid="B28-toxins-11-00034" ref-type="bibr">28</xref>,<xref rid="B29-toxins-11-00034" ref-type="bibr">29</xref>,<xref rid="B30-toxins-11-00034" ref-type="bibr">30</xref>].</p></sec><sec id="sec5-toxins-11-00034"><title>5. BoNTs Are Designed to Kill a Distant Host</title><p>In most of the infectious bacterial diseases, bacteria colonize the host organism they affect. With the BoNT-producing bacteria, the situation is very different (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>). Indeed, they produce a toxin that affects their final targets (i.e., the nerve terminals) in a host living at a distance, spatially and chronologically, from the site where the bacteria replicate. Foodborne botulism is due to the ingestion of a preformed toxin contained in inadequately preserved food (human), poorly prepared silage (cattle) or decaying organic matter or carcasses (many animal species). Live maggots feeding on carcasses can accumulate enough toxin to cause foodborne botulism in their vertebrate predators, without being poisoned by BoNTs [<xref rid="B31-toxins-11-00034" ref-type="bibr">31</xref>,<xref rid="B32-toxins-11-00034" ref-type="bibr">32</xref>]. Remarkably, host intoxication can occur a long time, days up to years, after the neurotoxin has been synthetized and even after bacterial death, such as in matrices preventing <italic>C. botulinum</italic> sporulation, for example, in some canned foods [<xref rid="B33-toxins-11-00034" ref-type="bibr">33</xref>,<xref rid="B34-toxins-11-00034" ref-type="bibr">34</xref>]. This is possible thanks to the exceptional stability of the NTNH&#x02013;BoNT complexes to acidic pH and to proteolytic degradation [<xref rid="B9-toxins-11-00034" ref-type="bibr">9</xref>]. Thus, BoNT can pass through the digestive tract (i.e., through the very acidic and protease-rich stomach as well as the proteolytic intestinal content) in a non-inactivated form. Thereby, BoNTs can cross without damaging several physiological barriers such as the stomach and intestinal epithelium [<xref rid="B35-toxins-11-00034" ref-type="bibr">35</xref>,<xref rid="B36-toxins-11-00034" ref-type="bibr">36</xref>]. During foodborne and infant botulism, BoNT molecules undergo passage through the stomach and/or intestinal epithelium [<xref rid="B35-toxins-11-00034" ref-type="bibr">35</xref>,<xref rid="B36-toxins-11-00034" ref-type="bibr">36</xref>], either by transcytosis through intestinal epithelial cells [<xref rid="B37-toxins-11-00034" ref-type="bibr">37</xref>] or through the paracellular way thanks to the interaction of HAs with E-cadherin and subsequent disruption of intercellular junctions [<xref rid="B35-toxins-11-00034" ref-type="bibr">35</xref>,<xref rid="B38-toxins-11-00034" ref-type="bibr">38</xref>]. Dissemination of BoNTs in the body through blood and lymph circulation allows BoNT molecules to reach the peripheral nerve endings [<xref rid="B35-toxins-11-00034" ref-type="bibr">35</xref>,<xref rid="B36-toxins-11-00034" ref-type="bibr">36</xref>]. BoNT cannot gain direct access to the central nervous system (CNS) across the blood&#x02013;brain barrier [<xref rid="B36-toxins-11-00034" ref-type="bibr">36</xref>,<xref rid="B37-toxins-11-00034" ref-type="bibr">37</xref>,<xref rid="B39-toxins-11-00034" ref-type="bibr">39</xref>,<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>]. However, similarly to TeNT, very minute amounts of BoNT can enter the CNS using a transcytosis mechanism in neurons via the retrograde pathway [<xref rid="B41-toxins-11-00034" ref-type="bibr">41</xref>]. Although BoNT receptors mediating the toxin entry into target neuronal cells have been extensively analyzed (review in [<xref rid="B42-toxins-11-00034" ref-type="bibr">42</xref>]), those driving BoNT sorting into retrograde transport vesicles remain to be defined.</p></sec><sec id="sec6-toxins-11-00034"><title>6. BoNTs Are Designed to Selectively Recognize Nerve Terminals and Exploit Synaptic Vesicle Recycling as a Trojan Horse to Enter into Them</title><p>What confers the exquisite neurotropic specificity of the neurotoxins? The C-terminus portion of Hc contains domains mediating binding to target nerve terminals through an interaction with double membrane receptors comprised of a poly-sialo-ganglioside acting as a low-affinity receptor in the vertebrates, enriched in the outer leaflet of plasma membranes of neuron nerve endings, and a high-affinity receptor consisting of a glycoprotein protein (review in [<xref rid="B42-toxins-11-00034" ref-type="bibr">42</xref>,<xref rid="B43-toxins-11-00034" ref-type="bibr">43</xref>]). It is noteworthy that the binding affinity of BoNTs for their receptors is in the same range as those of other potent lethal bacterial toxins (<xref rid="toxins-11-00034-t003" ref-type="table">Table 3</xref>). Thus, BoNTs are neurotoxins that recognize specific receptors on target neuronal cells, but they have not developed an exceptional binding affinity to interact with them. Overall, the BoNTs prefer complex gangliosides rather than a simple one. They have a considerably higher affinity for the b series gangliosides such as GT1b/GD1b, than with GM1 or GM3; binding to GD1a is high as well (review in [<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>,<xref rid="B42-toxins-11-00034" ref-type="bibr">42</xref>]). The preference for gangliosides varies with the toxinotype. For instance, the affinity of BoNT/A is high for GT1b &#x0003e; GD1b &#x0003e;&#x0003e; GM1 [<xref rid="B44-toxins-11-00034" ref-type="bibr">44</xref>]. BoNT/B affinity is high for GT1b and GD1a and much lower for GD1b and GM1 [<xref rid="B45-toxins-11-00034" ref-type="bibr">45</xref>] and that of BoNT/F is higher for GT1b and GD1a than for GM3 and very low for GD1b or GM1a [<xref rid="B46-toxins-11-00034" ref-type="bibr">46</xref>]. Of interest, the dominant forms of gangliosides in neurons are the complex forms including GM1, GD1a, GD1b, and GT1b, which are more enriched (1 to 2 order of magnitude higher) in nerve cell membranes than in other cell types [<xref rid="B47-toxins-11-00034" ref-type="bibr">47</xref>,<xref rid="B48-toxins-11-00034" ref-type="bibr">48</xref>], thereby explaining BoNT tropism for the nervous system.</p><p>Depending on the BoNT toxinotype, the protein receptor is one of the vesicle membrane proteins: N-linked glycan-SV2 (-A, -B, or -C) or synaptotagmin (&#x02212;1 or &#x02212;2). This interaction with a dual receptor on cell membrane avoids the binding of BoNT to non-receptive cells and facilitates specific trapping from the extracellular space and concentration into neuron endings. The two binding sites for gangliosides and glycoprotein, respectively, have been characterized on the HcC-terminal domain [<xref rid="B42-toxins-11-00034" ref-type="bibr">42</xref>,<xref rid="B43-toxins-11-00034" ref-type="bibr">43</xref>]. Interestingly, BoNT interaction with SV2 isoforms requires both the recognition of a protein domain and a glycan N-lined to SV2 [<xref rid="B49-toxins-11-00034" ref-type="bibr">49</xref>,<xref rid="B50-toxins-11-00034" ref-type="bibr">50</xref>]. The recognition of N-linked glycan in addition to the protein part of a receptor increases the specificity of the host&#x02013;pathogen or bacterial toxin interaction with target cells [<xref rid="B51-toxins-11-00034" ref-type="bibr">51</xref>]. BoNT/B, D/C, and G, which interact with synaptotagmin, use an additional interaction with the lipid membrane via a hydrophobic loop located in their Hc between the ganglioside and synaptotagmin binding sites [<xref rid="B52-toxins-11-00034" ref-type="bibr">52</xref>]. Moreover, both co-receptors (poly-ganglioside + protein) have to be co-localized into the same membrane microdomain [<xref rid="B53-toxins-11-00034" ref-type="bibr">53</xref>]. Thus, during evolution, Hc looks to be tuned for maximizing the interaction of BoNT with neuron endings, thereby facilitating its ensuing neuronal uptake. Indeed, SV2 and synaptotagmin are integral proteins of synaptic vesicle membrane whose luminal domain is exposed onto the nerve-ending surface upon the collapse of synaptic vesicles with the plasma membrane during neurotransmitter exocytosis. This allows the trapping of BoNT inside recycling synaptic vesicles, the acidification of which triggers the translocation of Lc into the cytosol, and at the same time, the disulfide bridge linking Lc to Hc is reduced, making Lc free in the cytosol and unmasking its catalytic cleft [<xref rid="B42-toxins-11-00034" ref-type="bibr">42</xref>,<xref rid="B54-toxins-11-00034" ref-type="bibr">54</xref>,<xref rid="B55-toxins-11-00034" ref-type="bibr">55</xref>,<xref rid="B56-toxins-11-00034" ref-type="bibr">56</xref>,<xref rid="B57-toxins-11-00034" ref-type="bibr">57</xref>]. Hence, recycling synaptic vesicles act as the main Trojan horse (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>) that introduces the neurotoxins into the nerve terminals at only a few tens or even hundreds of nanometers from the site where their final molecular targets, the soluble N-ethylmaleimide-sensitive-factor attachment protein receptor (SNAREs), are concentrated.</p></sec><sec id="sec7-toxins-11-00034"><title>7. BoNTs Are Not Super-Enzymes but Their Effect Is Amplified at Many Steps of Their Action</title><p>Lc is a Zn-dependent metalloprotease [<xref rid="B67-toxins-11-00034" ref-type="bibr">67</xref>]. In the cytosol, depending on the BoNT toxinotype, Lc specifically cleaves only one of the three SNARE proteins (either synaptosomal nerve-associated protein 25 (SNAP-25), vesicle-associated membrane protein (VAMP)/synaptobrevin, or syntaxin) (<xref rid="toxins-11-00034-t001" ref-type="table">Table 1</xref>). The high proteolytic specificity of Lc for a unique substrate results from a pairing of one to two SNARE motifs (in addition to the cleavage site) with exosites present in the Lc catalytic cleft [<xref rid="B68-toxins-11-00034" ref-type="bibr">68</xref>,<xref rid="B69-toxins-11-00034" ref-type="bibr">69</xref>,<xref rid="B70-toxins-11-00034" ref-type="bibr">70</xref>]. Given the key role for the SNAREs in mediating the fusion of synaptic vesicles with plasma membrane exocytosis, their cleavage results in a blockade of Ca<sup>2+</sup>-dependent exocytosis of neurotransmitters (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>).</p><p>Not only BoNTs inhibit neurotransmission, but they also do it over a long term. Indeed, whereas the lifespan of these neurotoxins in extracellular media is in the range of several days, this is not the case when they are intra-neuronal. Here, their lifespan is in the range of several weeks to months (reviewed in [<xref rid="B71-toxins-11-00034" ref-type="bibr">71</xref>]). The longest-acting one is BoNT/A Lc. Its interaction with a cytosolic des-ubiquitin ligase prevents its ubiquitinylation and ensuing entry into the proteasome degradation pathway [<xref rid="B72-toxins-11-00034" ref-type="bibr">72</xref>,<xref rid="B73-toxins-11-00034" ref-type="bibr">73</xref>,<xref rid="B74-toxins-11-00034" ref-type="bibr">74</xref>]. This allows for maintaining the inhibition of exocytosis for months, despite the rapid re-synthesis of the cleaved SNAREs. However, the lifetime of Lc in neuronal cells is probably not the only factor involved in the duration of BoNT effects. Indeed, SNARE complexes likely adopt a radial arrangement, and this supports the idea that SNAP25 cleaved by BoNT/A does not impair the SNARE complex assembly but acts as dominant negative SNARE oligomer that can have a long-duration inhibitory effect on neuroexocytosis machinery [<xref rid="B75-toxins-11-00034" ref-type="bibr">75</xref>,<xref rid="B76-toxins-11-00034" ref-type="bibr">76</xref>].</p><p>As mentioned above, BoNTs undergo a long journey between the distant site of their production (mostly in food or intestine) and the nerve endings where they act (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>). Along this journey, they pass through several physiological barriers at the price of large dilution in body fluids, so that only tiny amounts reach nerve terminals (far below picomolar concentrations during the disease). Therefore, with regard to their very high lethality (a range of 100 million mice LD50/mg neurotoxins; LD ~0.2 ng/kg in case of BoNT/A), one would expect their Lc to be a super protease. However, this is not the case. Their enzymatic kinetic parameters, as investigated with BoNT/A Lc and its substrate SNAP25, revealed an enzymatic performance which is far from exceptional. The number of SNAP25 molecules cleaved by a BoNT/A Lc molecules per second (kcat) is rather low (k<sub>cat</sub> = 17.1 s<sup>&#x02212;1</sup> [<xref rid="B77-toxins-11-00034" ref-type="bibr">77</xref>,<xref rid="B78-toxins-11-00034" ref-type="bibr">78</xref>], k<sub>cat</sub> = 0.51 mn<sup>&#x02212;1</sup> (0.0085 s<sup>&#x02212;1</sup>) [<xref rid="B79-toxins-11-00034" ref-type="bibr">79</xref>]). This is slightly lower than other bacterial proteases (k<sub>cat</sub> of thermolysin-like zinc-dependent protease of <italic>Bacillus stearothermophilus</italic> = 180 s<sup>&#x02212;1</sup>) [<xref rid="B80-toxins-11-00034" ref-type="bibr">80</xref>]. Why are BoNTs so deadly? It turns out that their incredible lethality results from a unique combination of two factors. First of all, the neurotoxins attack our Achilles&#x02019; heel: the system of communication between neurons and essential effectors such as muscles and glands, without which life cannot occur. Second, many steps optimize or even amplify their deleterious action (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>):
<list list-type="simple"><list-item><label>(i)</label><p>The chaperoning of BoNT by NTNH minimizes acidic pH and protease degradation upon passing through the upper digestive tract;</p></list-item><list-item><label>(ii)</label><p>Receptor-mediated transcytosis and/or HA-dependent paracellular passage allows the bypassing of physiological barriers (intestinal barrier or endothelial barrier);</p></list-item><list-item><label>(iii)</label><p>Specific receptors on neuronal cells trap and concentrate the toxin molecules on target cells avoiding diffusion and dilution in non-productive host compartments;</p></list-item><list-item><label>(iv)</label><p>Receptor-mediated internalization by recycling vesicles optimizes neurotoxin uptake at the precise site where their molecular targets (the SNAREs) are accumulated;</p></list-item><list-item><label>(v)</label><p>Nerve endings contain hundreds (most central synapses) up to several tens of thousands (motoneuron) of synaptic vesicles. Their fusion with a plasma membrane can occur only in very specialized regions (i.e., release sites) of the plasma membrane called active zones, the number of which is limited at each nerve ending. For a fusion event, a ring of several SNARE complexes should be formed at the interface of a given synaptic vesicle and plasma membrane at the release site [<xref rid="B81-toxins-11-00034" ref-type="bibr">81</xref>]. Following cleavage by BoNT, SNAREs can form non-productive complexes. Therefore, synaptic vesicles can continue docking on release sites but do not fuse due to the presence of one or a few unproductive SNARE complexes in the ring [<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>,<xref rid="B81-toxins-11-00034" ref-type="bibr">81</xref>]. Since these vesicles cannot fuse nor be retrieved, the number of release sites able to experience exocytosis decreases, as demonstrated after the cleavage of VAMP/synaptobrevin [<xref rid="B82-toxins-11-00034" ref-type="bibr">82</xref>]. Thus, the cleavage of a small proportion of the SNAREs is sufficient to silence synaptic neurotransmission [<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>,<xref rid="B81-toxins-11-00034" ref-type="bibr">81</xref>];</p></list-item><list-item><label>(vi)</label><p>The long duration of the Lc of some BoNT types such as BoNT/A, which is the most potent BoNT, inside the target cells and the long duration of activity;</p></list-item><list-item><label>(vii)</label><p>At the neuromuscular junction, there is no need for a complete blockade of exocytosis to get complete paralysis [<xref rid="B83-toxins-11-00034" ref-type="bibr">83</xref>]. As soon as the number of synaptic vesicles fusing with plasma membrane in response to motor command is too low to induce subthreshold post-synaptic responses, muscle fiber contraction does not occur and muscle contraction weakens;</p></list-item><list-item><label>(viii)</label><p>Asphyxia and subsequent death do not need the complete paralysis of the diaphragm and pharyngeal muscles. It occurs when muscle weakness is sufficient not to allow enough gas exchange (i.e., a vital capacity below 15 mL/kg body weight in humans) as reported for peripheral neuropathies [<xref rid="B84-toxins-11-00034" ref-type="bibr">84</xref>]. This may explain why the lethal dose of BoNT/A in mice (25 g) by the intraperitoneal route is 3.7 pg [<xref rid="B85-toxins-11-00034" ref-type="bibr">85</xref>] or 7 pg for highly purified recombinant toxin [<xref rid="B86-toxins-11-00034" ref-type="bibr">86</xref>], whereas the ex-vivo nerve-hemidiaphragm assay requires 10 to 20 more toxin molecule numbers [<xref rid="B87-toxins-11-00034" ref-type="bibr">87</xref>].</p></list-item></list></p><p>Overall, BoNTs are not super enzymatically active but super efficient (<xref ref-type="fig" rid="toxins-11-00034-f001">Figure 1</xref>). Their very high potency results from a unique combination of in vivo steps, each with a limited incremental effect, the accumulation of which confers to this non-cytotoxic toxin the ability to kill large organisms. This situation is unique among bacterial toxins. The other bacterial toxins that display high lethal toxicity just below the BoNTs are diphtheria toxin, <italic>Clostridium perfringens</italic> epsilon toxin and <italic>Clostridium sordellii</italic> lethal toxin [<xref rid="B88-toxins-11-00034" ref-type="bibr">88</xref>]. In contrast to BoNTs, they are highly cytotoxic for their target cells, and this critical step is responsible for their pathological effects [<xref rid="B89-toxins-11-00034" ref-type="bibr">89</xref>,<xref rid="B90-toxins-11-00034" ref-type="bibr">90</xref>,<xref rid="B91-toxins-11-00034" ref-type="bibr">91</xref>,<xref rid="B92-toxins-11-00034" ref-type="bibr">92</xref>,<xref rid="B93-toxins-11-00034" ref-type="bibr">93</xref>].</p></sec><sec id="sec8-toxins-11-00034"><title>8. What about the BoNT Origin?</title><p>A large number of distinct bacteria share the same property of producing a BoNT, albeit of diverse types or subtypes. This raises the question of the origin of the BoNTs. The high level of amino acid sequences and the structural identity of all the BoNTs types and subtypes as well as NTNH proteins associated to BoNTs strongly support the possibility that they derive from a common ancestor gene. What are the gene spreading mechanisms involved in making so many different bacterial strains produce BoNTs or display <italic>bont</italic>-related genes? <italic>bont</italic> genes and those encoding non-toxic associated proteins (NTNH, HAs, or OrfX) are localized in a locus (botulinum locus) which is flanked by insertion sequences and is located in various DNA structures (chromosome, plasmid, phage, transposon or transposon-like DNA elements). Such a localization of DNA mobile elements, notably plasmid and phages, accounts for horizontal gene transfer between various clostridial strains [<xref rid="B94-toxins-11-00034" ref-type="bibr">94</xref>,<xref rid="B95-toxins-11-00034" ref-type="bibr">95</xref>,<xref rid="B96-toxins-11-00034" ref-type="bibr">96</xref>], and possibly also between clostridia and other bacterial species. For instance, the gene of the novel BoNT/En (i.e., BoNT/J) is located in the <italic>E. faecium</italic> conjugative plasmid possibly acquired from a <italic>Clostridium</italic> strain [<xref rid="B23-toxins-11-00034" ref-type="bibr">23</xref>]. In most of the <italic>C. botulinum</italic> B strains, the botulinum locus is located in plasmids and shows a high genetic diversity even inside each subtype [<xref rid="B97-toxins-11-00034" ref-type="bibr">97</xref>]. In addition, most of the clostridial bivalent strains include a botulinum locus type B, suggesting that these strains are highly receptive to the acquisition/transfer of mobile elements such as plasmids and are highly susceptible to DNA modifications [<xref rid="B95-toxins-11-00034" ref-type="bibr">95</xref>,<xref rid="B98-toxins-11-00034" ref-type="bibr">98</xref>,<xref rid="B99-toxins-11-00034" ref-type="bibr">99</xref>]. <italic>C. tetani</italic> produces a TeNT that is closely related to BoNT/B and shares with it the same cleavage site in its SNARE target [<xref rid="B67-toxins-11-00034" ref-type="bibr">67</xref>]. Similar to the <italic>bont</italic> B gene, the <italic>tent</italic> gene is also located on a large-sized plasmid, and BoNT/B shares the highest level of its amino acid identity with TeNT. However, <italic>tent</italic> is not associated with non-toxic protein encoding genes. Therefore, the question of whether BoNT/B results from genetic transfer and the subsequent modification of <italic>tent</italic> from <italic>C. tetani</italic>, or vice-versa, is open. Interestingly, the <italic>ntnh</italic> gene is conserved in all BoNT-producing clostridia and is located just upstream of the <italic>bont</italic> gene with which it forms an operon, supporting the idea that <italic>bont</italic> and <italic>ntnh</italic> result from duplication of a common ancestor gene. Indeed, NTNH retains the same size as BoNT, and both NTNH and BoNTs are structurally related [<xref rid="B9-toxins-11-00034" ref-type="bibr">9</xref>,<xref rid="B39-toxins-11-00034" ref-type="bibr">39</xref>]. Is there a common ancestor of clostridial neurotoxin genes with duplication in <italic>bont</italic> and <italic>ntnh</italic> genes in <italic>C. botulinum</italic> in contrast to the single <italic>tent</italic> gene in <italic>C. tetani</italic>? It has been hypothesized that the clostridial neurotoxins have arisen from a viral protease fused to transmembrane and receptor domains [<xref rid="B100-toxins-11-00034" ref-type="bibr">100</xref>]. However, the mode of genetic transfer between virus and clostridia is hypothetical. <italic>C. botulinum</italic> C and D contain phages harboring <italic>bont</italic>, but these phages share no significant homology with other phages or viruses [<xref rid="B101-toxins-11-00034" ref-type="bibr">101</xref>].</p></sec><sec id="sec9-toxins-11-00034"><title>9. Distribution of BoNT-Producing Bacteria</title><p>Until now, the established BoNT-producer has been clostridia. The usual habitat of clostridia is an anaerobic environment: soil, dust, sediment, cadavers, manure, and, depending on the species, the intestinal content of healthy animals (mammals such as, pigs, birds, and fishes). Although <italic>C. botulinum</italic> strains are widely distributed in the environment, there still exist geographical variations in the prevalence of certain toxinotypes. Type A and B strains are found in soils that are poor in organic matter, and more rarely in aquatic sediment. Overall, <italic>C. botulinum</italic> type A is predominant in the western part of the United States (west of the Missouri and Mississippi rivers), in soil that is neutral to alkaline (average pH 7.5) with a lower than average organic content. In contrast, type B prevails largely in the eastern part of the United States, and central and western Europe. B strains are recovered in slightly more acidic soil and sediments (average pH 6.25) with a higher level of organic matter content, and mainly in cultivated soils (pasture, fields) [<xref rid="B102-toxins-11-00034" ref-type="bibr">102</xref>,<xref rid="B103-toxins-11-00034" ref-type="bibr">103</xref>,<xref rid="B104-toxins-11-00034" ref-type="bibr">104</xref>]. Group II <italic>C. botulinum</italic> strains (<italic>C. botulinum</italic> E, non-proteolytic <italic>C. botulinum</italic> B and F) can grow and produce toxin at low temperatures. Therefore, <italic>C. botulinum</italic> E is predominant in the northern part of Europe (Scandinavia, Finland), America (Canada, Alaska) and Asia [<xref rid="B103-toxins-11-00034" ref-type="bibr">103</xref>] whereas <italic>C. botulinum</italic> B from group I and unexpectedly also from group II are more prevalent in warmer areas. Moreover, <italic>C. botulinum</italic> B is a frequent inhabitant of the digestive tract of healthy pigs while <italic>C. botulinum</italic> E is often found in the intestinal content of fish and aquatic animals living in northern countries [<xref rid="B103-toxins-11-00034" ref-type="bibr">103</xref>,<xref rid="B105-toxins-11-00034" ref-type="bibr">105</xref>,<xref rid="B106-toxins-11-00034" ref-type="bibr">106</xref>]. Thus, BoNT-producing clostridia show certain distinct environmental distributions that reflect their different physiological properties better than the production of different BoNT types. The distribution of the non-toxic <italic>C. botulinum</italic> counterparts has not been thoroughly investigated. It is noteworthy that clostridia are widespread in the environment. For example, clostridia, and notably <italic>C. butyricum,</italic> are one of the most abundant bacterial groups in lake sediments and sludge [<xref rid="B107-toxins-11-00034" ref-type="bibr">107</xref>,<xref rid="B108-toxins-11-00034" ref-type="bibr">108</xref>]. Based on their physiological properties, such as their tolerance/sensitivity to oxygen, the requirement of an appropriate pH, temperature, substrate for growth, and spore production/germination, the repartition of <italic>Clostridium</italic> species in the environment is heterogeneous. Saccharolytic clostridia such as <italic>C. butyricum</italic> and <italic>C. baratii</italic> preferentially grow in carbohydrate-rich environments, notably in decomposing vegetables and fruits, whereas proteolytic and gelatinolytic <italic>Clostridium</italic> including toxigenic and non-toxigenic <italic>C. botulinum</italic> strains that poorly sporulate are mainly found in animal cadavers or soil/sediments rich in organic material [<xref rid="B12-toxins-11-00034" ref-type="bibr">12</xref>]. The basis of the adaptation of metabolic pathways to particular substrates and/or to host defenses by the distinct <italic>C. botulinum</italic> types and subtypes remain to be elucidated.</p></sec><sec id="sec10-toxins-11-00034"><title>10. Why So Potent, and for What Purpose?</title><p>A current idea is that the production of potent toxins able to kill specific animal hosts might facilitate the survival and dissemination of BoNT-producing strains in the environment by providing appropriate substrates from animal cadavers [<xref rid="B31-toxins-11-00034" ref-type="bibr">31</xref>,<xref rid="B32-toxins-11-00034" ref-type="bibr">32</xref>]. Is this, overall, the case with neurotoxigenic clostridia? Apparently not: the non-toxigenic strain derivatives by the loss of <italic>bont</italic> genes (loss of phage, plasmid, and mobile DNA elements, for example) can grow and sporulate as well as their neurotoxigenic counterparts. In addition, the toxigenic strains closely related to non-toxigenic clostridial species are widespread in the environment, further arguing that toxigenicity is not a prerequisite of survival in the environment [<xref rid="B97-toxins-11-00034" ref-type="bibr">97</xref>,<xref rid="B98-toxins-11-00034" ref-type="bibr">98</xref>]. The most striking example is <italic>Clostridium sporogenes</italic>, which is commonly considered as a non-toxic counterpart of group I <italic>C. botulinum</italic> strains. The genomic analysis of <italic>C. sporogenes</italic> shows that most strains, albeit highly related (93% average nucleotide identity) to <italic>C. botulinum</italic> group I strains, contain specific clade-genetic signatures and constitute a distinct bacterial species than <italic>C. botulinum</italic>. However, some <italic>C. sporogenes</italic> strains have lost these signatures and are phylogenetically clustered with <italic>C. botulinum</italic> group I strains [<xref rid="B97-toxins-11-00034" ref-type="bibr">97</xref>,<xref rid="B109-toxins-11-00034" ref-type="bibr">109</xref>]. Horizontal <italic>bont</italic> gene transfer has been demonstrated between strains from <italic>C. botulinum</italic> group I and <italic>C. sporogenes</italic>, further supporting the high genetic relatedness between them [<xref rid="B96-toxins-11-00034" ref-type="bibr">96</xref>]. <italic>C. sporogenes</italic> is a frequent inhabitant of the environment, notably in milk, milk products, and canned foods [<xref rid="B110-toxins-11-00034" ref-type="bibr">110</xref>,<xref rid="B111-toxins-11-00034" ref-type="bibr">111</xref>], and is widely used as a <italic>C. botulinum</italic> surrogate in testing commercial food processing procedures [<xref rid="B112-toxins-11-00034" ref-type="bibr">112</xref>,<xref rid="B113-toxins-11-00034" ref-type="bibr">113</xref>]. This again further supports the idea that <italic>bont</italic> does not confer a specific advantage in <italic>Clostridium</italic>&#x02019;s survival and spread in the environment. Therefore, what is the evolutionary pressure driving <italic>bont</italic> gene-spreading in a number of bacterial species (as mentioned above)? Moreover, we face another unusual situation: BoNT-producing bacteria live in an anaerobic environment and their toxins act on very distant hosts living in an aerobic environment. Even in the case of wound botulism [<xref rid="B25-toxins-11-00034" ref-type="bibr">25</xref>], the anaerobic environment in which they grow (necrotic abscess) is not due to BoNT action but to the favorable conditions of necrotic tissue similar to those that can be found in the natural environment. The intestinal content is also an anaerobic environment, but the physiological microbiota is not favorable to the growth of these environmental bacteria [<xref rid="B32-toxins-11-00034" ref-type="bibr">32</xref>]. It is worthwhile to note that the BoNTs responsible for the most frequent forms of foodborne botulism in human and cattle are produced in preserved food (type A and B for humans) and silage (type C, D for cattle), which are recent human artefacts, which cannot have been anticipated by evolution.</p><p>Are vertebrates the only possible hosts? The SNAREs are evolutionarily highly conserved among all eukaryotes [<xref rid="B114-toxins-11-00034" ref-type="bibr">114</xref>]. However, the SNAREs harboring the cleavage sites attacked by BoNT or the closely-related TeNT look to appear with the nervous system of the metazoans, which exploit the Ca<sup>2+</sup>-regulated exocytosis of neurotransmitters, mediated by a specific subset of SNAREs and using synaptotagmin as a Ca<sup>2+</sup>-sensor. Indeed, SNAREs susceptible to cleavage by BoNT or TeNT are expressed in the neurons and endocrine cells of many invertebrate and vertebrate phylla. Intracellular neurotoxin or Lc expression bypassing the limiting membrane steps leads to exocytosis inhibition in Echinoidea (as sea urchin), Annelida (as the leech), Mollusca (as <italic>Aplysia</italic>, squid), Arthropoda (as crayfish or the fruit fly <italic>Drosophila</italic>), and in almost all the vertebrates (fish, birds, mammals) [<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>,<xref rid="B81-toxins-11-00034" ref-type="bibr">81</xref>]. Therefore, all metazoans are potential sensitive hosts for BoNTs. However, harboring a cleavable SNARE is not sufficient for designing a potential host. Indeed, invertebrates look not to be susceptible to botulism [<xref rid="B31-toxins-11-00034" ref-type="bibr">31</xref>,<xref rid="B115-toxins-11-00034" ref-type="bibr">115</xref>,<xref rid="B116-toxins-11-00034" ref-type="bibr">116</xref>] and the impairment of neurotransmission in them needs a very high extracellular concentration of BoNT (10 nM in <italic>A. californica</italic>) [<xref rid="B117-toxins-11-00034" ref-type="bibr">117</xref>]. Indeed, a key limiting step in the poisoning mechanisms is receptor-mediated internalization. Although the protein receptors of some BoNTs, such as synaptotagmins (&#x02212;1, &#x02212;2), are well conserved during evolution; this is not the case for N-linked glycan SV2 isoforms that are lacking in invertebrates (although vertebrates and invertebrates shares the non-glycosylated SV2-related-protein SVOP [<xref rid="B118-toxins-11-00034" ref-type="bibr">118</xref>]). Moreover, invertebrates, except echinoderms, do not synthetize the gangliosides [<xref rid="B48-toxins-11-00034" ref-type="bibr">48</xref>] that increase BoNT&#x02019;s binding affinity to neurons. Hence, the victims/hosts of prototypic BoNTs in natural conditions seem to be members of the vertebrata sub-phylum and not invertebrates. However, it is conceivable that, during evolution, the binding domain in BoNT Hc may have evolved to facilitate the exploitation of other membrane receptors, allowing these modified toxins to attack the invertebrate nervous system. If so, what would be the clinical manifestations of the disease in invertebrates?</p><p>It is difficult to conceive of what kind of evolutionary pressure pushed the clostridia to develop such sophisticated neurotropic weapons, with the ultimate &#x02018;purpose&#x02019; of killing animals and moreover at a distance from the bacterial multiplication site. Is this to create, from time to time, a large anaerobic fermentor [<xref rid="B32-toxins-11-00034" ref-type="bibr">32</xref>]? Perhaps we are barking up the wrong tree: indeed, the production of BoNT might be a &#x0201c;quality&#x0201d; independent from bacterial survival, as recently proposed [<xref rid="B119-toxins-11-00034" ref-type="bibr">119</xref>], which does not confer any advantage to the bacteria. Thereby, botulism might be the result of accidental encounters between unfortunate receptive hosts and neurotoxigenic environmental bacteria rather than a beneficial and prerequisite interaction for the pathogen. However, this type of accident looks to be highly frequent enough to have exerted some evolutionary pressure on the hosts: SNARE mutations conferring resistance to cleavage concentrates in certain highly exposed animal species (rat and chicken VAMP-2 [<xref rid="B40-toxins-11-00034" ref-type="bibr">40</xref>,<xref rid="B67-toxins-11-00034" ref-type="bibr">67</xref>,<xref rid="B81-toxins-11-00034" ref-type="bibr">81</xref>]. Does the genetic diversity of clostridia strains and corresponding BoNT variants involved in the various forms of botulism (foodborne, infant, intestinal, and wound botulism) reflect the fact that the strains are found in the environment where the host is living rather than a pathogen adaptation to a specific host [<xref rid="B18-toxins-11-00034" ref-type="bibr">18</xref>,<xref rid="B33-toxins-11-00034" ref-type="bibr">33</xref>,<xref rid="B120-toxins-11-00034" ref-type="bibr">120</xref>,<xref rid="B121-toxins-11-00034" ref-type="bibr">121</xref>]? Since <italic>bont</italic>-related genes have been recently identified in other bacteria than <italic>Clostridia</italic> (see above <xref ref-type="sec" rid="sec3-toxins-11-00034">Section 3</xref>), it is conceivable that BoNT-ancestor related toxins and corresponding hosts will be discovered in the future, shedding light on the evolutionary mechanisms pushing many bacteria to adopt such a potent toxin arsenal.</p></sec><sec id="sec11-toxins-11-00034"><title>11. Concluding Remarks</title><p>It is to our discredit that we have failed to answer the introductory questions: the mystery still remains. Indeed, what the protease ancestor gene could be that gives rise to the unique situations that different bacteria share closely related toxins remains to be elucidated. Even more enigmatic is why and how environmental bacteria have acquired such sophisticated and active toxins characterized by extreme specificity towards highly specialized proteins from the metazoan neural machinery of neuroexocytosis. What is the advantage for them to produce a lethal toxin that can kill a host at a distance from the bacterial replication site? Since the identification of botulism as a natural poison-caused disease by Justinus Kerner [<xref rid="B122-toxins-11-00034" ref-type="bibr">122</xref>,<xref rid="B123-toxins-11-00034" ref-type="bibr">123</xref>], two centuries of hard work have been necessary to understand botulism&#x02019;s mechanisms at the molecular level. The natural history of the BoNTs and their producing bacteria is still in progress. From the suspicion of a neurotoxic compound in some contaminated foods responsible for a severe neurological disease to the characterization of BoNT activity in the neuroexocytosis process at the molecular and structural levels, a major breakthrough has been reached. However, a complete understanding of these toxins, which show a great diversity and use a sophisticated multi-step activity to become the most potent toxins, remains to be further developed.</p></sec></body><back><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxins-11-00034"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Clostridial toxins as therapeuic agents: Benefits and nature&#x02019;s most toxic proteins</article-title><source>Annu. Rev. Microbiol.</source><year>1999</year><volume>53</volume><fpage>551</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.53.1.551</pub-id><?supplied-pmid 10547701?><pub-id pub-id-type="pmid">10547701</pub-id></element-citation></ref><ref id="B2-toxins-11-00034"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schantz</surname><given-names>E.J.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Properties and use of botulinum toxin and other microbial neurotoxins in medicine</article-title><source>Microbiol. Rev.</source><year>1992</year><volume>56</volume><fpage>80</fpage><lpage>99</lpage><?supplied-pmid 1579114?><pub-id pub-id-type="pmid">1579114</pub-id></element-citation></ref><ref id="B3-toxins-11-00034"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>M.W.</given-names></name></person-group><article-title><italic>Clostridium botulinum</italic> and the safety of minimally heated, chilled foods: An emerging issue?</article-title><source>J. Appl. Microbiol.</source><year>2006</year><volume>101</volume><fpage>556</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2006.02987.x</pub-id><?supplied-pmid 16907806?><pub-id pub-id-type="pmid">16907806</pub-id></element-citation></ref><ref id="B4-toxins-11-00034"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barash</surname><given-names>J.R.</given-names></name><name><surname>Arnon</surname><given-names>S.S.</given-names></name></person-group><article-title>A Novel Strain of <italic>Clostridium botulinum</italic> That Produces Type B and Type H Botulinum Toxins</article-title><source>J. Infect. Dis.</source><year>2014</year><volume>209</volume><fpage>183</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit449</pub-id><?supplied-pmid 24106296?><pub-id pub-id-type="pmid">24106296</pub-id></element-citation></ref><ref id="B5-toxins-11-00034"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maslanka</surname><given-names>S.E.</given-names></name><name><surname>Luquez</surname><given-names>C.</given-names></name><name><surname>Dykes</surname><given-names>J.K.</given-names></name><name><surname>Tepp</surname><given-names>W.H.</given-names></name><name><surname>Pier</surname><given-names>C.L.</given-names></name><name><surname>Pellett</surname><given-names>S.</given-names></name><name><surname>Raphael</surname><given-names>B.H.</given-names></name><name><surname>Kalb</surname><given-names>S.R.</given-names></name><name><surname>Barr</surname><given-names>J.R.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><etal/></person-group><article-title>A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure with Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized with Serotype A Antitoxin</article-title><source>J. Infect. Dis.</source><year>2016</year><volume>213</volume><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiv327</pub-id><?supplied-pmid 26068781?><pub-id pub-id-type="pmid">26068781</pub-id></element-citation></ref><ref id="B6-toxins-11-00034"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellett</surname><given-names>S.</given-names></name><name><surname>Tepp</surname><given-names>W.H.</given-names></name><name><surname>Bradshaw</surname><given-names>M.</given-names></name><name><surname>Kalb</surname><given-names>S.R.</given-names></name><name><surname>Dykes</surname><given-names>J.K.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Nawrocki</surname><given-names>E.M.</given-names></name><name><surname>Pier</surname><given-names>C.L.</given-names></name><name><surname>Barr</surname><given-names>J.R.</given-names></name><name><surname>Maslanka</surname><given-names>S.E.</given-names></name><etal/></person-group><article-title>Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified <italic>Clostridium botulinum</italic> Strain</article-title><source>mSphere</source><year>2016</year><volume>1</volume><pub-id pub-id-type="doi">10.1128/mSphere.00100-15</pub-id><?supplied-pmid 27303710?><pub-id pub-id-type="pmid">27303710</pub-id></element-citation></ref><ref id="B7-toxins-11-00034"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Masuyer</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Lundin</surname><given-names>D.</given-names></name><name><surname>Henriksson</surname><given-names>L.</given-names></name><name><surname>Miyashita</surname><given-names>S.I.</given-names></name><name><surname>Martinez-Carranza</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Stenmark</surname><given-names>P.</given-names></name></person-group><article-title>Identification and characterization of a novel botulinum neurotoxin</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>14130</fpage><pub-id pub-id-type="doi">10.1038/ncomms14130</pub-id><pub-id pub-id-type="pmid">28770820</pub-id></element-citation></ref><ref id="B8-toxins-11-00034"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>M.W.</given-names></name><name><surname>Smith</surname><given-names>T.J.</given-names></name><name><surname>Anniballi</surname><given-names>F.</given-names></name><name><surname>Austin</surname><given-names>J.W.</given-names></name><name><surname>Bano</surname><given-names>L.</given-names></name><name><surname>Bradshaw</surname><given-names>M.</given-names></name><name><surname>Cuervo</surname><given-names>P.</given-names></name><name><surname>Cheng</surname><given-names>L.W.</given-names></name><name><surname>Derman</surname><given-names>Y.</given-names></name><name><surname>Dorner</surname><given-names>B.G.</given-names></name><etal/></person-group><article-title>Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature</article-title><source>Toxins (Basel)</source><year>2017</year><volume>9</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.3390/toxins9010038</pub-id></element-citation></ref><ref id="B9-toxins-11-00034"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Rumpel</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Strotmeier</surname><given-names>J.</given-names></name><name><surname>Bigalke</surname><given-names>H.</given-names></name><name><surname>Perry</surname><given-names>K.</given-names></name><name><surname>Shoemaker</surname><given-names>C.B.</given-names></name><name><surname>Rummel</surname><given-names>A.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name></person-group><article-title>Botulinum neurotoxin is shielded by NTNHA in an interlocked complex</article-title><source>Science</source><year>2012</year><volume>335</volume><fpage>977</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1126/science.1214270</pub-id><pub-id pub-id-type="pmid">22363010</pub-id></element-citation></ref><ref id="B10-toxins-11-00034"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name></person-group><article-title>Assembly and function of the botulinum neurotoxin progenitor complex</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2013</year><volume>364</volume><fpage>21</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">23239347</pub-id></element-citation></ref><ref id="B11-toxins-11-00034"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>M.W.</given-names></name><name><surname>Stringer</surname><given-names>S.C.</given-names></name><name><surname>Carter</surname><given-names>A.T.</given-names></name></person-group><article-title><italic>Clostridium botulinum</italic> in the post-genomic era</article-title><source>Food Microbiol.</source><year>2011</year><volume>28</volume><fpage>183</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.fm.2010.03.005</pub-id><?supplied-pmid 21315972?><pub-id pub-id-type="pmid">21315972</pub-id></element-citation></ref><ref id="B12-toxins-11-00034"><label>12.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Popoff</surname><given-names>M.R.</given-names></name><name><surname>Mazuet</surname><given-names>C.</given-names></name><name><surname>Poulain</surname><given-names>B.</given-names></name></person-group><article-title>Botulism and Tetanus</article-title><source>The Prokaryotes: Human Microbiology</source><edition>4th ed.</edition><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2013</year><volume>Volume 5</volume><fpage>247</fpage><lpage>290</lpage></element-citation></ref><ref id="B13-toxins-11-00034"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anniballi</surname><given-names>F.</given-names></name><name><surname>Fillo</surname><given-names>S.</given-names></name><name><surname>Giordani</surname><given-names>F.</given-names></name><name><surname>Auricchio</surname><given-names>B.</given-names></name><name><surname>Tehran</surname><given-names>D.A.</given-names></name><name><surname>di Stefano</surname><given-names>E.</given-names></name><name><surname>Mandarino</surname><given-names>G.</given-names></name><name><surname>De Medici</surname><given-names>D.</given-names></name><name><surname>Lista</surname><given-names>F.</given-names></name></person-group><article-title>Multiple-locus variable number of tandem repeat analysis as a tool for molecular epidemiology of botulism: The Italian experience</article-title><source>Infect. Genet. Evol.</source><year>2016</year><volume>46</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.10.014</pub-id><?supplied-pmid 27771520?><pub-id pub-id-type="pmid">27771520</pub-id></element-citation></ref><ref id="B14-toxins-11-00034"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fillo</surname><given-names>S.</given-names></name><name><surname>Giordani</surname><given-names>F.</given-names></name><name><surname>Anniballi</surname><given-names>F.</given-names></name><name><surname>Gorge</surname><given-names>O.</given-names></name><name><surname>Ramisse</surname><given-names>V.</given-names></name><name><surname>Vergnaud</surname><given-names>G.</given-names></name><name><surname>Riehm</surname><given-names>J.M.</given-names></name><name><surname>Scholz</surname><given-names>H.C.</given-names></name><name><surname>Splettstoesser</surname><given-names>W.D.</given-names></name><name><surname>Kieboom</surname><given-names>J.</given-names></name><etal/></person-group><article-title><italic>Clostridium botulinum</italic> Group I Strain Genotyping by 15-Locus Multilocus Variable-Number Tandem-Repeat Analysis</article-title><source>J. Clin. Microbiol.</source><year>2011</year><volume>49</volume><fpage>4252</fpage><lpage>4263</lpage><pub-id pub-id-type="doi">10.1128/JCM.05396-11</pub-id><pub-id pub-id-type="pmid">22012011</pub-id></element-citation></ref><ref id="B15-toxins-11-00034"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>M.J.</given-names></name><name><surname>Lin</surname><given-names>G.</given-names></name><name><surname>Whittam</surname><given-names>T.S.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Phylogenetic analysis of <italic>Clostridium botulinum</italic> type A by multi-locus sequence typing</article-title><source>Microbiology</source><year>2008</year><volume>154</volume><fpage>2408</fpage><lpage>2415</lpage><pub-id pub-id-type="doi">10.1099/mic.0.2008/016915-0</pub-id><?supplied-pmid 18667573?><pub-id pub-id-type="pmid">18667573</pub-id></element-citation></ref><ref id="B16-toxins-11-00034"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>T.E.</given-names></name><name><surname>Helma</surname><given-names>C.H.</given-names></name><name><surname>Ticknor</surname><given-names>L.O.</given-names></name><name><surname>Jackson</surname><given-names>P.J.</given-names></name><name><surname>Okinaka</surname><given-names>R.T.</given-names></name><name><surname>Smith</surname><given-names>L.A.</given-names></name><name><surname>Smith</surname><given-names>T.J.</given-names></name><name><surname>Hill</surname><given-names>K.K.</given-names></name></person-group><article-title>Differentiation of <italic>Clostridium botulinum</italic> serotype A strains by multiple-locus variable-number tandem-repeat analysis</article-title><source>Appl. Environ. Microbiol.</source><year>2008</year><volume>74</volume><fpage>875</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1128/AEM.01539-07</pub-id><?supplied-pmid 18083878?><pub-id pub-id-type="pmid">18083878</pub-id></element-citation></ref><ref id="B17-toxins-11-00034"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umeda</surname><given-names>K.</given-names></name><name><surname>Wada</surname><given-names>T.</given-names></name><name><surname>Kohda</surname><given-names>T.</given-names></name><name><surname>Kozaki</surname><given-names>S.</given-names></name></person-group><article-title>Multi-locus variable number tandem repeat analysis for <italic>Clostridium botulinum</italic> type B isolates in Japan: Comparison with other isolates and genotyping methods</article-title><source>Infect. Genet. Evol.</source><year>2013</year><volume>16</volume><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.02.022</pub-id><pub-id pub-id-type="pmid">23499776</pub-id></element-citation></ref><ref id="B18-toxins-11-00034"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazuet</surname><given-names>C.</given-names></name><name><surname>Legeay</surname><given-names>C.</given-names></name><name><surname>Sautereau</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Bouchier</surname><given-names>C.</given-names></name><name><surname>Bouvet</surname><given-names>P.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Diversity of Group I and II <italic>Clostridium botulinum</italic> Strains from France Including Recently Identified Subtypes</article-title><source>Genome Biol. Evol.</source><year>2016</year><volume>8</volume><fpage>1643</fpage><lpage>1660</lpage><pub-id pub-id-type="doi">10.1093/gbe/evw101</pub-id><pub-id pub-id-type="pmid">27189984</pub-id></element-citation></ref><ref id="B19-toxins-11-00034"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>M.J.</given-names></name><name><surname>Adams</surname><given-names>J.B.</given-names></name><name><surname>Doxey</surname><given-names>A.C.</given-names></name></person-group><article-title>Botulinum neurotoxin homologs in non-Clostridium species</article-title><source>FEBS Lett.</source><year>2015</year><volume>589</volume><fpage>342</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2014.12.018</pub-id><pub-id pub-id-type="pmid">25541486</pub-id></element-citation></ref><ref id="B20-toxins-11-00034"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strahan</surname><given-names>B.L.</given-names></name><name><surname>Failor</surname><given-names>K.C.</given-names></name><name><surname>Batties</surname><given-names>A.M.</given-names></name><name><surname>Hayes</surname><given-names>P.S.</given-names></name><name><surname>Cicconi</surname><given-names>K.M.</given-names></name><name><surname>Mason</surname><given-names>C.T.</given-names></name><name><surname>Newman</surname><given-names>J.D.</given-names></name></person-group><article-title><italic>Chryseobacterium piperi</italic> sp. nov., isolated from a freshwater creek</article-title><source>Int. J. Syst. Evol. Microbiol.</source><year>2011</year><volume>61</volume><fpage>2162</fpage><lpage>2166</lpage><pub-id pub-id-type="doi">10.1099/ijs.0.027805-0</pub-id><pub-id pub-id-type="pmid">20889766</pub-id></element-citation></ref><ref id="B21-toxins-11-00034"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wentz</surname><given-names>T.G.</given-names></name><name><surname>Muruvanda</surname><given-names>T.</given-names></name><name><surname>Lomonaco</surname><given-names>S.</given-names></name><name><surname>Thirunavukkarasu</surname><given-names>N.</given-names></name><name><surname>Hoffmann</surname><given-names>M.</given-names></name><name><surname>Allard</surname><given-names>M.W.</given-names></name><name><surname>Hodge</surname><given-names>D.R.</given-names></name><name><surname>Pillai</surname><given-names>S.P.</given-names></name><name><surname>Hammack</surname><given-names>T.S.</given-names></name><name><surname>Brown</surname><given-names>E.W.</given-names></name><etal/></person-group><article-title>Closed Genome Sequence of <italic>Chryseobacterium piperi</italic> Strain CTM(T)/ATCC BAA-1782, a Gram-Negative Bacterium with Clostridial Neurotoxin-Like Coding Sequences</article-title><source>Genome Announc.</source><year>2017</year><volume>5</volume><fpage>e01296-17</fpage><pub-id pub-id-type="doi">10.1128/genomeA.01296-17</pub-id><pub-id pub-id-type="pmid">29192076</pub-id></element-citation></ref><ref id="B22-toxins-11-00034"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunt</surname><given-names>J.</given-names></name><name><surname>Carter</surname><given-names>A.T.</given-names></name><name><surname>Stringer</surname><given-names>S.C.</given-names></name><name><surname>Peck</surname><given-names>M.W.</given-names></name></person-group><article-title>Identification of a novel botulinum neurotoxin gene cluster in <italic>Enterococcus</italic></article-title><source>FEBS Lett.</source><year>2018</year><volume>592</volume><fpage>310</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12969</pub-id><?supplied-pmid 29323697?><pub-id pub-id-type="pmid">29323697</pub-id></element-citation></ref><ref id="B23-toxins-11-00034"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Lebreton</surname><given-names>F.</given-names></name><name><surname>Mansfield</surname><given-names>M.J.</given-names></name><name><surname>Miyashita</surname><given-names>S.I.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Schwartzman</surname><given-names>J.A.</given-names></name><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Masuyer</surname><given-names>G.</given-names></name><name><surname>Martinez-Carranza</surname><given-names>M.</given-names></name><name><surname>Stenmark</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium</article-title><source>Cell Host Microbe</source><year>2018</year><volume>23</volume><fpage>169</fpage><lpage>176.e6</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.12.018</pub-id><?supplied-pmid 29396040?><pub-id pub-id-type="pmid">29396040</pub-id></element-citation></ref><ref id="B24-toxins-11-00034"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>J.M.</given-names></name><name><surname>Blumenthal</surname><given-names>J.R.</given-names></name><name><surname>Merson</surname><given-names>M.H.</given-names></name><name><surname>Lombard</surname><given-names>G.L.</given-names></name><name><surname>Dowell</surname><given-names>V.R.</given-names><suffix>Jr.</suffix></name><name><surname>Gangarosa</surname><given-names>E.J.</given-names></name></person-group><article-title>Clinical features of types A and B food-borne botulism</article-title><source>Ann. Intern. Med.</source><year>1981</year><volume>95</volume><fpage>442</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-95-4-442</pub-id><?supplied-pmid 7283294?><pub-id pub-id-type="pmid">7283294</pub-id></element-citation></ref><ref id="B25-toxins-11-00034"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobel</surname><given-names>J.</given-names></name></person-group><article-title>Botulism</article-title><source>Clin. Infect. Dis.</source><year>2005</year><volume>41</volume><fpage>1167</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.1086/444507</pub-id><?supplied-pmid 16163636?><pub-id pub-id-type="pmid">16163636</pub-id></element-citation></ref><ref id="B26-toxins-11-00034"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Sumner</surname><given-names>C.J.</given-names></name><name><surname>Castor</surname><given-names>M.</given-names></name><name><surname>Maslanka</surname><given-names>S.</given-names></name><name><surname>Sobel</surname><given-names>J.</given-names></name></person-group><article-title>Adult botulism type F in the United States, 1981&#x02013;2002</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1694</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000187127.92446.4c</pub-id><pub-id pub-id-type="pmid">16344510</pub-id></element-citation></ref><ref id="B27-toxins-11-00034"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenicia</surname><given-names>L.</given-names></name><name><surname>Anniballi</surname><given-names>F.</given-names></name><name><surname>Aureli</surname><given-names>P.</given-names></name></person-group><article-title>Intestinal toxemia botulism in Italy, 1984&#x02013;2005</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2007</year><volume>26</volume><fpage>385</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1007/s10096-007-0301-9</pub-id><?supplied-pmid 17516104?><pub-id pub-id-type="pmid">17516104</pub-id></element-citation></ref><ref id="B28-toxins-11-00034"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosow</surname><given-names>L.K.</given-names></name><name><surname>Strober</surname><given-names>J.B.</given-names></name></person-group><article-title>Infant botulism: Review and clinical update</article-title><source>Pediatr. Neurol.</source><year>2015</year><volume>52</volume><fpage>487</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2015.01.006</pub-id><?supplied-pmid 25882077?><pub-id pub-id-type="pmid">25882077</pub-id></element-citation></ref><ref id="B29-toxins-11-00034"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindstr&#x000f4;m</surname><given-names>M.</given-names></name><name><surname>Myllykoski</surname><given-names>J.</given-names></name><name><surname>Sivela</surname><given-names>S.</given-names></name><name><surname>Korkeala</surname><given-names>H.</given-names></name></person-group><article-title><italic>Clostridium botulinum</italic> in cattle and dairy products</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2010</year><volume>50</volume><fpage>281</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1080/10408390802544405</pub-id><pub-id pub-id-type="pmid">20301016</pub-id></element-citation></ref><ref id="B30-toxins-11-00034"><label>30.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Uzal</surname><given-names>F.</given-names></name><name><surname>Songer</surname><given-names>J.G.</given-names></name><name><surname>Prescott</surname><given-names>J.F.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><source>Clostridial Diseases of Animals</source><publisher-name>Wiley Balckwell</publisher-name><publisher-loc>Ames, IA, USA</publisher-loc><year>2016</year><fpage>332</fpage></element-citation></ref><ref id="B31-toxins-11-00034"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espelund</surname><given-names>M.</given-names></name><name><surname>Klaveness</surname><given-names>D.</given-names></name></person-group><article-title>Botulism outbreaks in natural environments&#x02014;An update</article-title><source>Front. Microbiol.</source><year>2014</year><volume>5</volume><fpage>287</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00287</pub-id><pub-id pub-id-type="pmid">24966853</pub-id></element-citation></ref><ref id="B32-toxins-11-00034"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>R.M.</given-names></name></person-group><article-title>Botulinum Neurotoxin Diversity from a Gene-Centered View</article-title><source>Toxins (Basel)</source><year>2018</year><volume>10</volume><elocation-id>310</elocation-id><pub-id pub-id-type="doi">10.3390/toxins10080310</pub-id></element-citation></ref><ref id="B33-toxins-11-00034"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>A.T.</given-names></name><name><surname>Peck</surname><given-names>M.W.</given-names></name></person-group><article-title>Genomes, neurotoxins and biology of <italic>Clostridium botulinum</italic> Group I and Group II</article-title><source>Res. Microbiol.</source><year>2015</year><volume>166</volume><fpage>303</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2014.10.010</pub-id><?supplied-pmid 25445012?><pub-id pub-id-type="pmid">25445012</pub-id></element-citation></ref><ref id="B34-toxins-11-00034"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lund</surname><given-names>B.M.</given-names></name><name><surname>Peck</surname><given-names>M.W.</given-names></name></person-group><article-title><italic>Clostridium</italic>&#x000a0;<italic>botulinum</italic></article-title><source>Guide to Foodborne Pathogens</source><person-group person-group-type="editor"><name><surname>Labb&#x000e9;</surname><given-names>R.G.</given-names></name><name><surname>Garcia</surname><given-names>S.</given-names></name></person-group><publisher-name>John Willey</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2001</year><fpage>69</fpage><lpage>85</lpage></element-citation></ref><ref id="B35-toxins-11-00034"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujinaga</surname><given-names>Y.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Translocation and dissemination of botulinum neurotoxin from the intestinal tract</article-title><source>Toxicon</source><year>2018</year><volume>147</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2017.10.020</pub-id><?supplied-pmid 29074396?><pub-id pub-id-type="pmid">29074396</pub-id></element-citation></ref><ref id="B36-toxins-11-00034"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>L.</given-names></name></person-group><article-title>The life history of a botulinum toxin molecule</article-title><source>Toxicon</source><year>2013</year><volume>68</volume><fpage>40</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2013.02.014</pub-id><?supplied-pmid 23518040?><pub-id pub-id-type="pmid">23518040</pub-id></element-citation></ref><ref id="B37-toxins-11-00034"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Connan</surname><given-names>C.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Uptake of Clostridial Neurotoxins into Cells and Dissemination</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2017</year><volume>406</volume><fpage>39</fpage><lpage>78</lpage><?supplied-pmid 28879524?><pub-id pub-id-type="pmid">28879524</pub-id></element-citation></ref><ref id="B38-toxins-11-00034"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujinaga</surname><given-names>Y.</given-names></name><name><surname>Sugawara</surname><given-names>Y.</given-names></name><name><surname>Matsumura</surname><given-names>T.</given-names></name></person-group><article-title>Uptake of botulinum neurotoxin in the intestine</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2013</year><volume>364</volume><fpage>45</fpage><lpage>59</lpage><?supplied-pmid 23239348?><pub-id pub-id-type="pmid">23239348</pub-id></element-citation></ref><ref id="B39-toxins-11-00034"><label>39.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Poulain</surname><given-names>B.</given-names></name><name><surname>Molgo</surname><given-names>J.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Clostridial neurotoxins: From the cellular and molecular mode of action to their therapeutic use</article-title><source>The Comprehensive Sourcebook of Bacterial Protein Toxins</source><edition>4th ed.</edition><person-group person-group-type="editor"><name><surname>Alouf</surname><given-names>J.</given-names></name><name><surname>Ladant</surname><given-names>D.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2015</year><fpage>287</fpage><lpage>336</lpage></element-citation></ref><ref id="B40-toxins-11-00034"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulain</surname><given-names>B.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name><name><surname>Molgo</surname><given-names>J.</given-names></name></person-group><article-title>How do the botulinum neurotoxins block neurotransmitter release: From botulism to the molecular mechanism of action</article-title><source>Botulinum J.</source><year>2008</year><volume>1</volume><fpage>14</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1504/TBJ.2008.018951</pub-id></element-citation></ref><ref id="B41-toxins-11-00034"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzocchio</surname><given-names>R.</given-names></name><name><surname>Caleo</surname><given-names>M.</given-names></name></person-group><article-title>More than at the neuromuscular synapse: Actions of botulinum neurotoxin A in the central nervous system</article-title><source>Neuroscientist</source><year>2015</year><volume>21</volume><fpage>44</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1177/1073858414524633</pub-id><pub-id pub-id-type="pmid">24576870</pub-id></element-citation></ref><ref id="B42-toxins-11-00034"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rummel</surname><given-names>A.</given-names></name></person-group><article-title>Two Feet on the Membrane: Uptake of Clostridial Neurotoxins</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2017</year><volume>406</volume><fpage>1</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">27921176</pub-id></element-citation></ref><ref id="B43-toxins-11-00034"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>K.H.</given-names></name><name><surname>Yao</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name></person-group><article-title>Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin</article-title><source>Prog. Biophys. Mol. Biol.</source><year>2015</year><volume>117</volume><fpage>225</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2015.02.004</pub-id><pub-id pub-id-type="pmid">25701633</pub-id></element-citation></ref><ref id="B44-toxins-11-00034"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yowler</surname><given-names>B.C.</given-names></name><name><surname>Kensinger</surname><given-names>R.D.</given-names></name><name><surname>Schengrund</surname><given-names>C.L.</given-names></name></person-group><article-title>Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>32815</fpage><lpage>32819</lpage><pub-id pub-id-type="doi">10.1074/jbc.M205258200</pub-id><pub-id pub-id-type="pmid">12089155</pub-id></element-citation></ref><ref id="B45-toxins-11-00034"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiki</surname><given-names>T.</given-names></name><name><surname>Tokuyama</surname><given-names>Y.</given-names></name><name><surname>Kamata</surname><given-names>Y.</given-names></name><name><surname>Nemoto</surname><given-names>Y.</given-names></name><name><surname>Yoshida</surname><given-names>A.</given-names></name><name><surname>Sekiguchi</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Kozaki</surname><given-names>S.</given-names></name></person-group><article-title>Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA</article-title><source>Neurosci. Lett.</source><year>1996</year><volume>208</volume><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(96)12557-X</pub-id><pub-id pub-id-type="pmid">8859901</pub-id></element-citation></ref><ref id="B46-toxins-11-00034"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Barbieri</surname><given-names>J.T.</given-names></name><name><surname>Kim</surname><given-names>J.J.</given-names></name><name><surname>Baldwin</surname><given-names>M.R.</given-names></name></person-group><article-title>Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>5631</fpage><lpage>5641</lpage><pub-id pub-id-type="doi">10.1021/bi9002138</pub-id><?supplied-pmid 19476346?><pub-id pub-id-type="pmid">19476346</pub-id></element-citation></ref><ref id="B47-toxins-11-00034"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamori</surname><given-names>M.</given-names></name><name><surname>Shimomura</surname><given-names>J.</given-names></name><name><surname>Tsuyuhara</surname><given-names>S.</given-names></name><name><surname>Nagai</surname><given-names>Y.</given-names></name></person-group><article-title>Gangliosides of various rat tissues: Distribution of ganglio-N-tetraose-containing gangliosides and tissue-characteristic composition of gangliosides</article-title><source>J. Biochem.</source><year>1984</year><volume>95</volume><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a134667</pub-id><?supplied-pmid 6725233?><pub-id pub-id-type="pmid">6725233</pub-id></element-citation></ref><ref id="B48-toxins-11-00034"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolter</surname><given-names>T.</given-names></name></person-group><article-title>Ganglioside biochemistry</article-title><source>ISRN Biochem.</source><year>2012</year><volume>2012</volume><fpage>506160</fpage><pub-id pub-id-type="doi">10.5402/2012/506160</pub-id><pub-id pub-id-type="pmid">25969757</pub-id></element-citation></ref><ref id="B49-toxins-11-00034"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Mahrhold</surname><given-names>S.</given-names></name><name><surname>Lam</surname><given-names>K.H.</given-names></name><name><surname>Stern</surname><given-names>D.</given-names></name><name><surname>Bagramyan</surname><given-names>K.</given-names></name><name><surname>Perry</surname><given-names>K.</given-names></name><name><surname>Kalkum</surname><given-names>M.</given-names></name><name><surname>Rummel</surname><given-names>A.</given-names></name><name><surname>Dong</surname><given-names>M.</given-names></name><etal/></person-group><article-title>N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A</article-title><source>Nat. Struct. Mol. Biol.</source><year>2016</year><volume>23</volume><fpage>656</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3245</pub-id><?supplied-pmid 27294781?><pub-id pub-id-type="pmid">27294781</pub-id></element-citation></ref><ref id="B50-toxins-11-00034"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Tepp</surname><given-names>W.H.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name><name><surname>Janz</surname><given-names>R.</given-names></name><name><surname>Chapman</surname><given-names>E.R.</given-names></name></person-group><article-title>Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons</article-title><source>Mol. Biol. Cell</source><year>2008</year><volume>19</volume><fpage>5226</fpage><lpage>5237</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-07-0765</pub-id><?supplied-pmid 18815274?><pub-id pub-id-type="pmid">18815274</pub-id></element-citation></ref><ref id="B51-toxins-11-00034"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdoulous</surname><given-names>S.</given-names></name><name><surname>Lemichez</surname><given-names>E.</given-names></name></person-group><article-title>Decoding glycan recognition by bacterial toxins</article-title><source>Nat. Microbiol.</source><year>2018</year><volume>3</volume><fpage>124</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0107-9</pub-id><pub-id pub-id-type="pmid">29358681</pub-id></element-citation></ref><ref id="B52-toxins-11-00034"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>D.</given-names></name><name><surname>Weisemann</surname><given-names>J.</given-names></name><name><surname>Le Blanc</surname><given-names>A.</given-names></name><name><surname>von Berg</surname><given-names>L.</given-names></name><name><surname>Mahrhold</surname><given-names>S.</given-names></name><name><surname>Piesker</surname><given-names>J.</given-names></name><name><surname>Laue</surname><given-names>M.</given-names></name><name><surname>Luppa</surname><given-names>P.B.</given-names></name><name><surname>Dorner</surname><given-names>M.B.</given-names></name><name><surname>Dorner</surname><given-names>B.G.</given-names></name><etal/></person-group><article-title>A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><elocation-id>e1007048</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007048</pub-id><pub-id pub-id-type="pmid">29718991</pub-id></element-citation></ref><ref id="B53-toxins-11-00034"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desplantes</surname><given-names>R.</given-names></name><name><surname>Leveque</surname><given-names>C.</given-names></name><name><surname>Muller</surname><given-names>B.</given-names></name><name><surname>Lotierzo</surname><given-names>M.</given-names></name><name><surname>Ferracci</surname><given-names>G.</given-names></name><name><surname>Popoff</surname><given-names>M.</given-names></name><name><surname>Seagar</surname><given-names>M.</given-names></name><name><surname>Mamoun</surname><given-names>R.</given-names></name><name><surname>El Far</surname><given-names>O.</given-names></name></person-group><article-title>Affinity biosensors using recombinant native membrane proteins displayed on exosomes: Application to botulinum neurotoxin B receptor</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1032</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01198-1</pub-id><pub-id pub-id-type="pmid">28432329</pub-id></element-citation></ref><ref id="B54-toxins-11-00034"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Montal</surname><given-names>M.</given-names></name></person-group><article-title>Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>29604</fpage><lpage>29611</lpage><pub-id pub-id-type="doi">10.1074/jbc.M703619200</pub-id><pub-id pub-id-type="pmid">17666397</pub-id></element-citation></ref><ref id="B55-toxins-11-00034"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koriazova</surname><given-names>L.K.</given-names></name><name><surname>Montal</surname><given-names>M.</given-names></name></person-group><article-title>Translocation of botulinum neurotoxin light chain protease through the heavy chain channel</article-title><source>Nat. Struct. Biol.</source><year>2003</year><volume>10</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/nsb879</pub-id><?supplied-pmid 12459720?><pub-id pub-id-type="pmid">12459720</pub-id></element-citation></ref><ref id="B56-toxins-11-00034"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montal</surname><given-names>M.</given-names></name></person-group><article-title>Botulinum Neurotoxin: A Marvel of Protein Design</article-title><source>Annu. Rev. Biochem.</source><year>2010</year><volume>79</volume><fpage>591</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.051908.125345</pub-id><?supplied-pmid 20233039?><pub-id pub-id-type="pmid">20233039</pub-id></element-citation></ref><ref id="B57-toxins-11-00034"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surana</surname><given-names>S.</given-names></name><name><surname>Tosolini</surname><given-names>A.P.</given-names></name><name><surname>Meyer</surname><given-names>I.F.G.</given-names></name><name><surname>Fellows</surname><given-names>A.D.</given-names></name><name><surname>Novoselov</surname><given-names>S.S.</given-names></name><name><surname>Schiavo</surname><given-names>G.</given-names></name></person-group><article-title>The travel diaries of tetanus and botulinum neurotoxins</article-title><source>Toxicon</source><year>2018</year><volume>147</volume><fpage>58</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2017.10.008</pub-id><?supplied-pmid 29031941?><pub-id pub-id-type="pmid">29031941</pub-id></element-citation></ref><ref id="B58-toxins-11-00034"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Meng</surname><given-names>J.</given-names></name><name><surname>Nugent</surname><given-names>M.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Dolly</surname><given-names>J.O.</given-names></name></person-group><article-title>Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domain</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>44474</fpage><pub-id pub-id-type="doi">10.1038/srep44474</pub-id><?supplied-pmid 28295026?><pub-id pub-id-type="pmid">28295026</pub-id></element-citation></ref><ref id="B59-toxins-11-00034"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiki</surname><given-names>T.</given-names></name><name><surname>Kamata</surname><given-names>Y.</given-names></name><name><surname>Nemoto</surname><given-names>Y.</given-names></name><name><surname>Omori</surname><given-names>A.</given-names></name><name><surname>Ito</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Kozaki</surname><given-names>S.</given-names></name></person-group><article-title>Identification of protein receptor for <italic>Clostridium botulinum</italic> type B neurotoxin in rat brain synaptosomes</article-title><source>J. Biol. Chem.</source><year>1994</year><volume>269</volume><fpage>10498</fpage><lpage>10503</lpage><?supplied-pmid 8144634?><pub-id pub-id-type="pmid">8144634</pub-id></element-citation></ref><ref id="B60-toxins-11-00034"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Berntsson</surname><given-names>R.P.</given-names></name><name><surname>Liu</surname><given-names>S.M.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><name><surname>Boone</surname><given-names>C.</given-names></name><name><surname>Palan</surname><given-names>S.</given-names></name><name><surname>Beard</surname><given-names>M.</given-names></name><name><surname>Chabrier</surname><given-names>P.E.</given-names></name><etal/></person-group><article-title>Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>53</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00064-y</pub-id><?supplied-pmid 28674381?><pub-id pub-id-type="pmid">28674381</pub-id></element-citation></ref><ref id="B61-toxins-11-00034"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwamoto</surname><given-names>R.</given-names></name><name><surname>Higashiyama</surname><given-names>S.</given-names></name><name><surname>Mitamura</surname><given-names>T.</given-names></name><name><surname>Taniguchi</surname><given-names>N.</given-names></name><name><surname>Klagsbrun</surname><given-names>M.</given-names></name><name><surname>Mekada</surname><given-names>E.</given-names></name></person-group><article-title>Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity</article-title><source>EMBO J.</source><year>1994</year><volume>13</volume><fpage>2322</fpage><lpage>2330</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06516.x</pub-id><pub-id pub-id-type="pmid">8194524</pub-id></element-citation></ref><ref id="B62-toxins-11-00034"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shishido</surname><given-names>Y.</given-names></name><name><surname>Sharma</surname><given-names>K.D.</given-names></name><name><surname>Higashiyama</surname><given-names>S.</given-names></name><name><surname>Klagsbrun</surname><given-names>M.</given-names></name><name><surname>Mekada</surname><given-names>E.</given-names></name></person-group><article-title>Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>29578</fpage><lpage>29585</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.49.29578</pub-id><?supplied-pmid 7494001?><pub-id pub-id-type="pmid">7494001</pub-id></element-citation></ref><ref id="B63-toxins-11-00034"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wigelsworth</surname><given-names>D.J.</given-names></name><name><surname>Krantz</surname><given-names>B.A.</given-names></name><name><surname>Christensen</surname><given-names>K.A.</given-names></name><name><surname>Lacy</surname><given-names>D.B.</given-names></name><name><surname>Juris</surname><given-names>S.J.</given-names></name><name><surname>Collier</surname><given-names>R.J.</given-names></name></person-group><article-title>Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>23349</fpage><lpage>23356</lpage><pub-id pub-id-type="doi">10.1074/jbc.M401292200</pub-id><pub-id pub-id-type="pmid">15044490</pub-id></element-citation></ref><ref id="B64-toxins-11-00034"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scobie</surname><given-names>H.M.</given-names></name><name><surname>Thomas</surname><given-names>D.</given-names></name><name><surname>Marlett</surname><given-names>J.M.</given-names></name><name><surname>Destito</surname><given-names>G.</given-names></name><name><surname>Wigelsworth</surname><given-names>D.J.</given-names></name><name><surname>Collier</surname><given-names>R.J.</given-names></name><name><surname>Young</surname><given-names>J.A.</given-names></name><name><surname>Manchester</surname><given-names>M.</given-names></name></person-group><article-title>A soluble receptor decoy protects rats against anthrax lethal toxin challenge</article-title><source>J. Infect. Dis.</source><year>2005</year><volume>192</volume><fpage>1047</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1086/432731</pub-id><pub-id pub-id-type="pmid">16107958</pub-id></element-citation></ref><ref id="B65-toxins-11-00034"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagahama</surname><given-names>M.</given-names></name><name><surname>Sakurai</surname><given-names>J.</given-names></name></person-group><article-title>High-affinity binding of <italic>Clostridium perfringens</italic> epsilon-toxin to rat brain</article-title><source>Infect. Immun.</source><year>1992</year><volume>60</volume><fpage>1237</fpage><lpage>1240</lpage><?supplied-pmid 1541539?><pub-id pub-id-type="pmid">1541539</pub-id></element-citation></ref><ref id="B66-toxins-11-00034"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varela Chavez</surname><given-names>C.</given-names></name><name><surname>Hoos</surname><given-names>S.</given-names></name><name><surname>Haustant</surname><given-names>G.M.</given-names></name><name><surname>Chenal</surname><given-names>A.</given-names></name><name><surname>England</surname><given-names>P.</given-names></name><name><surname>Blondel</surname><given-names>A.</given-names></name><name><surname>Pauillac</surname><given-names>S.</given-names></name><name><surname>Lacy</surname><given-names>D.B.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>The catalytic domains of <italic>Clostridium sordellii</italic> lethal toxin and related large clostridial glucosylating toxins specifically recognize the negatively charged phospholipids phosphatidylserine and phosphatidic acid</article-title><source>Cell. Microbiol.</source><year>2015</year><volume>17</volume><fpage>1477</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1111/cmi.12449</pub-id><?supplied-pmid 25882477?><pub-id pub-id-type="pmid">25882477</pub-id></element-citation></ref><ref id="B67-toxins-11-00034"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavo</surname><given-names>G.</given-names></name><name><surname>Rossetto</surname><given-names>O.</given-names></name><name><surname>Santucci</surname><given-names>A.</given-names></name><name><surname>DasGupta</surname><given-names>B.R.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name></person-group><article-title>Botulinum neurotoxins are zinc proteins</article-title><source>J. Biol. Chem.</source><year>1992</year><volume>267</volume><fpage>23479</fpage><lpage>23483</lpage><?supplied-pmid 1429690?><pub-id pub-id-type="pmid">1429690</pub-id></element-citation></ref><ref id="B68-toxins-11-00034"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirazzini</surname><given-names>M.</given-names></name><name><surname>Rossetto</surname><given-names>O.</given-names></name><name><surname>Eleopra</surname><given-names>R.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name></person-group><article-title>Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology</article-title><source>Pharmacol. Rev.</source><year>2017</year><volume>69</volume><fpage>200</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1124/pr.116.012658</pub-id><?supplied-pmid 28356439?><pub-id pub-id-type="pmid">28356439</pub-id></element-citation></ref><ref id="B69-toxins-11-00034"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetto</surname><given-names>O.</given-names></name><name><surname>Schiavo</surname><given-names>G.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name><name><surname>Poulain</surname><given-names>B.</given-names></name><name><surname>Deloye</surname><given-names>F.</given-names></name><name><surname>Lozzi</surname><given-names>L.</given-names></name><name><surname>Shone</surname><given-names>C.C.</given-names></name></person-group><article-title>SNARE motif and neurotoxins</article-title><source>Nature</source><year>1994</year><volume>372</volume><fpage>415</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1038/372415a0</pub-id><?supplied-pmid 7984234?><pub-id pub-id-type="pmid">7984234</pub-id></element-citation></ref><ref id="B70-toxins-11-00034"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunger</surname><given-names>A.T.</given-names></name><name><surname>Rummel</surname><given-names>A.</given-names></name></person-group><article-title>Receptor and substrate interactions of clostridial neurotoxins</article-title><source>Toxicon</source><year>2009</year><volume>54</volume><fpage>550</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2008.12.027</pub-id><?supplied-pmid 19268493?><pub-id pub-id-type="pmid">19268493</pub-id></element-citation></ref><ref id="B71-toxins-11-00034"><label>71.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>Y.C.</given-names></name><name><surname>Moller</surname><given-names>B.E.</given-names></name><name><surname>Adler</surname><given-names>M.</given-names></name><name><surname>Oyler</surname><given-names>G.A.</given-names></name></person-group><article-title>Molecular basis for persistence of botulinum neurotoxin: THE role of intracellular protein degradation pathways</article-title><source>Molecular Aspects of Botulinum Neurotoxin</source><person-group person-group-type="editor"><name><surname>Foster</surname><given-names>K.A.</given-names></name></person-group><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2014</year><fpage>191</fpage><lpage>205</lpage></element-citation></ref><ref id="B72-toxins-11-00034"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>Y.C.</given-names></name><name><surname>Kotiya</surname><given-names>A.</given-names></name><name><surname>Kiris</surname><given-names>E.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Bavari</surname><given-names>S.</given-names></name><name><surname>Tessarollo</surname><given-names>L.</given-names></name><name><surname>Oyler</surname><given-names>G.A.</given-names></name><name><surname>Weissman</surname><given-names>A.M.</given-names></name></person-group><article-title>Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>E5158</fpage><lpage>E5166</lpage><pub-id pub-id-type="doi">10.1073/pnas.1621076114</pub-id><?supplied-pmid 28584101?><pub-id pub-id-type="pmid">28584101</pub-id></element-citation></ref><ref id="B73-toxins-11-00034"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>Y.C.</given-names></name><name><surname>Maditz</surname><given-names>R.</given-names></name><name><surname>Kuo</surname><given-names>C.L.</given-names></name><name><surname>Fishman</surname><given-names>P.S.</given-names></name><name><surname>Shoemaker</surname><given-names>C.B.</given-names></name><name><surname>Oyler</surname><given-names>G.A.</given-names></name><name><surname>Weissman</surname><given-names>A.M.</given-names></name></person-group><article-title>Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>16554</fpage><lpage>16559</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008302107</pub-id><pub-id pub-id-type="pmid">20823219</pub-id></element-citation></ref><ref id="B74-toxins-11-00034"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellett</surname><given-names>S.</given-names></name><name><surname>Bradshaw</surname><given-names>M.</given-names></name><name><surname>Tepp</surname><given-names>W.H.</given-names></name><name><surname>Pier</surname><given-names>C.L.</given-names></name><name><surname>Whitemarsh</surname><given-names>R.C.M.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Barbieri</surname><given-names>J.T.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes</article-title><source>MBio</source><year>2018</year><volume>9</volume><fpage>e00089-18</fpage><pub-id pub-id-type="doi">10.1128/mBio.00089-18</pub-id><pub-id pub-id-type="pmid">29588398</pub-id></element-citation></ref><ref id="B75-toxins-11-00034"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megighian</surname><given-names>A.</given-names></name><name><surname>Zordan</surname><given-names>M.</given-names></name><name><surname>Pantano</surname><given-names>S.</given-names></name><name><surname>Scorzeto</surname><given-names>M.</given-names></name><name><surname>Rigoni</surname><given-names>M.</given-names></name><name><surname>Zanini</surname><given-names>D.</given-names></name><name><surname>Rossetto</surname><given-names>O.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name></person-group><article-title>Evidence for a radial SNARE super-complex mediating neurotransmitter release at the Drosophila neuromuscular junction</article-title><source>J. Cell Sci.</source><year>2013</year><volume>126</volume><fpage>3134</fpage><lpage>3140</lpage><pub-id pub-id-type="doi">10.1242/jcs.123802</pub-id><pub-id pub-id-type="pmid">23687382</pub-id></element-citation></ref><ref id="B76-toxins-11-00034"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantano</surname><given-names>S.</given-names></name><name><surname>Montecucco</surname><given-names>C.</given-names></name></person-group><article-title>The blockade of the neurotransmitter release apparatus by botulinum neurotoxins</article-title><source>Cell. Mol. Life Sci.</source><year>2014</year><volume>71</volume><fpage>793</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1007/s00018-013-1380-7</pub-id><?supplied-pmid 23749048?><pub-id pub-id-type="pmid">23749048</pub-id></element-citation></ref><ref id="B77-toxins-11-00034"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binz</surname><given-names>T.</given-names></name><name><surname>Bade</surname><given-names>S.</given-names></name><name><surname>Rummel</surname><given-names>A.</given-names></name><name><surname>Kollewe</surname><given-names>A.</given-names></name><name><surname>Alves</surname><given-names>J.</given-names></name></person-group><article-title>Arg(326) and Tyr(365) of the botulinum neurotoxin type A light chain are involved in transition state stabilization</article-title><source>Biochemistry</source><year>2002</year><volume>41</volume><fpage>1717</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1021/bi0157969</pub-id><?supplied-pmid 11827515?><pub-id pub-id-type="pmid">11827515</pub-id></element-citation></ref><ref id="B78-toxins-11-00034"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebeda</surname><given-names>F.J.</given-names></name><name><surname>Cer</surname><given-names>R.Z.</given-names></name><name><surname>Mudunuri</surname><given-names>U.</given-names></name><name><surname>Stephens</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>B.R.</given-names></name><name><surname>Adler</surname><given-names>M.</given-names></name></person-group><article-title>The zinc-dependent protease activity of the botulinum neurotoxins</article-title><source>Toxins (Basel)</source><year>2010</year><volume>2</volume><fpage>978</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.3390/toxins2050978</pub-id><?supplied-pmid 22069621?><pub-id pub-id-type="pmid">22069621</pub-id></element-citation></ref><ref id="B79-toxins-11-00034"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Krilich</surname><given-names>J.</given-names></name><name><surname>Pellett</surname><given-names>S.</given-names></name><name><surname>Baudys</surname><given-names>J.</given-names></name><name><surname>Tepp</surname><given-names>W.H.</given-names></name><name><surname>Barr</surname><given-names>J.R.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name><name><surname>Kalb</surname><given-names>S.R.</given-names></name></person-group><article-title>Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5</article-title><source>Biochim. Biophys. Acta</source><year>2013</year><volume>1834</volume><fpage>2722</fpage><lpage>2728</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2013.09.007</pub-id><?supplied-pmid 24096023?><pub-id pub-id-type="pmid">24096023</pub-id></element-citation></ref><ref id="B80-toxins-11-00034"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaumont</surname><given-names>A.</given-names></name><name><surname>O&#x02019;Donohue</surname><given-names>M.J.</given-names></name><name><surname>Paredes</surname><given-names>N.</given-names></name><name><surname>Rousselet</surname><given-names>N.</given-names></name><name><surname>Assicot</surname><given-names>M.</given-names></name><name><surname>Bohuon</surname><given-names>C.</given-names></name><name><surname>Fournie-Zaluski</surname><given-names>M.C.</given-names></name><name><surname>Roques</surname><given-names>B.P.</given-names></name></person-group><article-title>The role of histidine 231 in thermolysin-like enzymes. A site-directed mutagenesis study</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>16803</fpage><lpage>16808</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.28.16803</pub-id><?supplied-pmid 7622493?><pub-id pub-id-type="pmid">7622493</pub-id></element-citation></ref><ref id="B81-toxins-11-00034"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humeau</surname><given-names>Y.</given-names></name><name><surname>Doussau</surname><given-names>F.</given-names></name><name><surname>Grant</surname><given-names>N.J.</given-names></name><name><surname>Poulain</surname><given-names>B.</given-names></name></person-group><article-title>How botulinum and tetanus neurotoxins block neurotransmitter release</article-title><source>Biochimie</source><year>2000</year><volume>82</volume><fpage>427</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/S0300-9084(00)00216-9</pub-id><pub-id pub-id-type="pmid">10865130</pub-id></element-citation></ref><ref id="B82-toxins-11-00034"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humeau</surname><given-names>Y.</given-names></name><name><surname>Doussau</surname><given-names>F.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name><name><surname>Benfenati</surname><given-names>F.</given-names></name><name><surname>Poulain</surname><given-names>B.</given-names></name></person-group><article-title>Fast changes in the functional status of release sites during short-term plasticity: Involvement of a frequency-dependent bypass of Rac at Aplysia synapses</article-title><source>J. Physiol.</source><year>2007</year><volume>583</volume><fpage>983</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2007.139899</pub-id><pub-id pub-id-type="pmid">17656428</pub-id></element-citation></ref><ref id="B83-toxins-11-00034"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgen</surname><given-names>A.S.</given-names></name><name><surname>Dickens</surname><given-names>F.</given-names></name><name><surname>Zatman</surname><given-names>L.J.</given-names></name></person-group><article-title>The action of botulinum toxin on the neuro-muscular junction</article-title><source>J. Physiol.</source><year>1949</year><volume>109</volume><fpage>10</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1949.sp004364</pub-id><pub-id pub-id-type="pmid">15394302</pub-id></element-citation></ref><ref id="B84-toxins-11-00034"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burakgazi</surname><given-names>A.Z.</given-names></name><name><surname>Hoke</surname><given-names>A.</given-names></name></person-group><article-title>Respiratory muscle weakness in peripheral neuropathies</article-title><source>J. Peripher. Nerv. Syst.</source><year>2010</year><volume>15</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1111/j.1529-8027.2010.00293.x</pub-id><pub-id pub-id-type="pmid">21199102</pub-id></element-citation></ref><ref id="B85-toxins-11-00034"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weisemann</surname><given-names>J.</given-names></name><name><surname>Krez</surname><given-names>N.</given-names></name><name><surname>Fiebig</surname><given-names>U.</given-names></name><name><surname>Worbs</surname><given-names>S.</given-names></name><name><surname>Skiba</surname><given-names>M.</given-names></name><name><surname>Endermann</surname><given-names>T.</given-names></name><name><surname>Dorner</surname><given-names>M.B.</given-names></name><name><surname>Bergstrom</surname><given-names>T.</given-names></name><name><surname>Munoz</surname><given-names>A.</given-names></name><name><surname>Zegers</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test</article-title><source>Toxins (Basel)</source><year>2015</year><volume>7</volume><fpage>5035</fpage><lpage>5054</lpage><pub-id pub-id-type="doi">10.3390/toxins7124861</pub-id><pub-id pub-id-type="pmid">26703728</pub-id></element-citation></ref><ref id="B86-toxins-11-00034"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worbs</surname><given-names>S.</given-names></name><name><surname>Fiebig</surname><given-names>U.</given-names></name><name><surname>Zeleny</surname><given-names>R.</given-names></name><name><surname>Schimmel</surname><given-names>H.</given-names></name><name><surname>Rummel</surname><given-names>A.</given-names></name><name><surname>Luginbuhl</surname><given-names>W.</given-names></name><name><surname>Dorner</surname><given-names>B.G.</given-names></name></person-group><article-title>Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test</article-title><source>Toxins (Basel)</source><year>2015</year><volume>7</volume><fpage>4935</fpage><lpage>4966</lpage><pub-id pub-id-type="doi">10.3390/toxins7124857</pub-id><?supplied-pmid 26703724?><pub-id pub-id-type="pmid">26703724</pub-id></element-citation></ref><ref id="B87-toxins-11-00034"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasetti-Escargueil</surname><given-names>C.</given-names></name><name><surname>Jones</surname><given-names>R.G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Sesardic</surname><given-names>D.</given-names></name></person-group><article-title>Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: Improved precision with in-bred mice</article-title><source>Toxicon</source><year>2009</year><volume>53</volume><fpage>503</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2009.01.019</pub-id><?supplied-pmid 19673096?><pub-id pub-id-type="pmid">19673096</pub-id></element-citation></ref><ref id="B88-toxins-11-00034"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>D.M.</given-names></name></person-group><article-title>Bacterial toxins: A table of lethal amounts</article-title><source>Microbiol. Rev.</source><year>1982</year><volume>46</volume><fpage>86</fpage><lpage>94</lpage><?supplied-pmid 6806598?><pub-id pub-id-type="pmid">6806598</pub-id></element-citation></ref><ref id="B89-toxins-11-00034"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Purification and characterization of <italic>Clostridium sordellii</italic> lethal toxin and cross-reactivity with <italic>Clostridium difficile</italic> cytotoxin</article-title><source>Infect. Immun.</source><year>1987</year><volume>55</volume><fpage>35</fpage><lpage>43</lpage><?supplied-pmid 3793234?><pub-id pub-id-type="pmid">3793234</pub-id></element-citation></ref><ref id="B90-toxins-11-00034"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>L.</given-names></name><name><surname>Maier</surname><given-names>E.</given-names></name><name><surname>Gibert</surname><given-names>M.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name><name><surname>Benz</surname><given-names>R.</given-names></name></person-group><article-title>Clostridium perfringens epsilon-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>15736</fpage><lpage>15740</lpage><pub-id pub-id-type="doi">10.1074/jbc.M010412200</pub-id><?supplied-pmid 11278669?><pub-id pub-id-type="pmid">11278669</pub-id></element-citation></ref><ref id="B91-toxins-11-00034"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popoff</surname><given-names>M.R.</given-names></name></person-group><article-title>Epsilon toxin: A fascinating pore-forming toxin</article-title><source>FEBS J.</source><year>2011</year><volume>278</volume><fpage>4602</fpage><lpage>4615</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08145.x</pub-id><?supplied-pmid 21535407?><pub-id pub-id-type="pmid">21535407</pub-id></element-citation></ref><ref id="B92-toxins-11-00034"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>R.J.</given-names></name></person-group><article-title>Diphtheria toxin: Mode of action and structure</article-title><source>Bacteriol. Rev.</source><year>1975</year><volume>39</volume><fpage>54</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">164179</pub-id></element-citation></ref><ref id="B93-toxins-11-00034"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wioland</surname><given-names>L.</given-names></name><name><surname>Dupont</surname><given-names>J.L.</given-names></name><name><surname>Bossu</surname><given-names>J.L.</given-names></name><name><surname>Popoff</surname><given-names>M.R.</given-names></name><name><surname>Poulain</surname><given-names>B.</given-names></name></person-group><article-title>Attack of the nervous system by Clostridium perfringens Epsilon toxin: From disease to mode of action on neural cells</article-title><source>Toxicon</source><year>2013</year><volume>75</volume><fpage>122</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2013.04.003</pub-id><pub-id pub-id-type="pmid">23632158</pub-id></element-citation></ref><ref id="B94-toxins-11-00034"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarin</surname><given-names>H.</given-names></name><name><surname>Segerman</surname><given-names>B.</given-names></name></person-group><article-title>Horizontal gene transfer of toxin genes in <italic>Clostridium botulinum</italic>: Involvement of mobile elements and plasmids</article-title><source>Mob. Genet. Elem.</source><year>2011</year><volume>1</volume><fpage>213</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.4161/mge.1.3.17617</pub-id></element-citation></ref><ref id="B95-toxins-11-00034"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>K.M.</given-names></name><name><surname>Bradshaw</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><elocation-id>e11087</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011087</pub-id><pub-id pub-id-type="pmid">20552020</pub-id></element-citation></ref><ref id="B96-toxins-11-00034"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nawrocki</surname><given-names>E.M.</given-names></name><name><surname>Bradshaw</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name></person-group><article-title>Botulinum neurotoxin-encoding plasmids can be conjugatively transferred to diverse clostridial strains</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>3100</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-21342-9</pub-id><?supplied-pmid 29449580?><pub-id pub-id-type="pmid">29449580</pub-id></element-citation></ref><ref id="B97-toxins-11-00034"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K.K.</given-names></name><name><surname>Smith</surname><given-names>T.J.</given-names></name><name><surname>Helma</surname><given-names>C.H.</given-names></name><name><surname>Ticknor</surname><given-names>L.O.</given-names></name><name><surname>Foley</surname><given-names>B.T.</given-names></name><name><surname>Svensson</surname><given-names>R.T.</given-names></name><name><surname>Brown</surname><given-names>J.L.</given-names></name><name><surname>Johnson</surname><given-names>E.A.</given-names></name><name><surname>Smith</surname><given-names>L.A.</given-names></name><name><surname>Okinaka</surname><given-names>R.T.</given-names></name><etal/></person-group><article-title>Genetic diversity among Botulinum Neurotoxin-producing clostridial strains</article-title><source>J. Bacteriol.</source><year>2007</year><volume>189</volume><fpage>818</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1128/JB.01180-06</pub-id><?supplied-pmid 17114256?><pub-id pub-id-type="pmid">17114256</pub-id></element-citation></ref><ref id="B98-toxins-11-00034"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K.K.</given-names></name><name><surname>Smith</surname><given-names>T.J.</given-names></name></person-group><article-title>Genetic diversity within <italic>Clostridium botulinum</italic> serotypes, botulinum neurotoxin gene clusters and toxin subtypes</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2013</year><volume>364</volume><fpage>1</fpage><lpage>20</lpage><?supplied-pmid 23239346?><pub-id pub-id-type="pmid">23239346</pub-id></element-citation></ref><ref id="B99-toxins-11-00034"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K.K.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Foley</surname><given-names>B.T.</given-names></name><name><surname>Smith</surname><given-names>T.J.</given-names></name></person-group><article-title>Genetic diversity within the botulinum neurotoxin-producing bacteria and their neurotoxins</article-title><source>Toxicon</source><year>2015</year><volume>107</volume><fpage>2</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2015.09.011</pub-id><pub-id pub-id-type="pmid">26368006</pub-id></element-citation></ref><ref id="B100-toxins-11-00034"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DasGupta</surname><given-names>B.R.</given-names></name></person-group><article-title>Botulinum neurotoxins: Perspective on their existence and as polyproteins harboring viral proteases</article-title><source>J. Gen. Appl. Microbiol.</source><year>2006</year><volume>52</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2323/jgam.52.1</pub-id><?supplied-pmid 16598153?><pub-id pub-id-type="pmid">16598153</pub-id></element-citation></ref><ref id="B101-toxins-11-00034"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Kurokawa</surname><given-names>K.</given-names></name><name><surname>Nakayama</surname><given-names>K.</given-names></name><name><surname>Oshima</surname><given-names>K.</given-names></name><name><surname>Fujinaga</surname><given-names>Y.</given-names></name><name><surname>Ohnishi</surname><given-names>M.</given-names></name><name><surname>Ohtsubo</surname><given-names>E.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name><name><surname>Oguma</surname><given-names>K.</given-names></name></person-group><article-title>The genome sequence of <italic>Clostridium botulinum</italic> type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>17472</fpage><lpage>17477</lpage><pub-id pub-id-type="doi">10.1073/pnas.0505503102</pub-id><?supplied-pmid 16287978?><pub-id pub-id-type="pmid">16287978</pub-id></element-citation></ref><ref id="B102-toxins-11-00034"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L.D.</given-names></name></person-group><article-title>The occurence of <italic>Clostridium botulinum</italic> and <italic>Clostridium tetani</italic> in the soil of the United States</article-title><source>Health Lab. Sci.</source><year>1978</year><volume>15</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">355208</pub-id></element-citation></ref><ref id="B103-toxins-11-00034"><label>103.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dodds</surname><given-names>K.L.</given-names></name></person-group><article-title><italic>Clostridium botulinum</italic> in the environment</article-title><source>Clostridium botulinum: Ecology and Control in Foods</source><person-group person-group-type="editor"><name><surname>Hauschild</surname><given-names>A.H.W.</given-names></name><name><surname>Dodds</surname><given-names>K.L.</given-names></name></person-group><publisher-name>Marcel Dekker, Inc.</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1993</year><fpage>21</fpage><lpage>51</lpage></element-citation></ref><ref id="B104-toxins-11-00034"><label>104.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hauschild</surname><given-names>A.H.W.</given-names></name></person-group><article-title><italic>Clostridium</italic>&#x000a0;<italic>botulinum</italic></article-title><source>Foodborne Bacterial Pathogens</source><person-group person-group-type="editor"><name><surname>Doyle</surname><given-names>M.P.</given-names></name></person-group><publisher-name>Marcel Dekker, Inc.</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1989</year><fpage>111</fpage><lpage>189</lpage></element-citation></ref><ref id="B105-toxins-11-00034"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlenborg</surname><given-names>M.</given-names></name><name><surname>Borch</surname><given-names>E.</given-names></name><name><surname>Radstrom</surname><given-names>P.</given-names></name></person-group><article-title>Development of a combined selection and enrichment PCR procedure for Clostridium botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs</article-title><source>Appl. Environ. Microbiol.</source><year>2001</year><volume>67</volume><fpage>4781</fpage><lpage>4788</lpage><pub-id pub-id-type="doi">10.1128/AEM.67.10.4781-4788.2001</pub-id><pub-id pub-id-type="pmid">11571185</pub-id></element-citation></ref><ref id="B106-toxins-11-00034"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myllykoski</surname><given-names>J.</given-names></name><name><surname>Nevas</surname><given-names>M.</given-names></name><name><surname>Lindstr&#x000f4;m</surname><given-names>M.</given-names></name><name><surname>Korkeala</surname><given-names>H.</given-names></name></person-group><article-title>The detection and prevalence of Clostridium botulinum in pig intestinal samples</article-title><source>Int. J. Food Microbiol.</source><year>2006</year><volume>110</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2006.04.017</pub-id><pub-id pub-id-type="pmid">16806550</pub-id></element-citation></ref><ref id="B107-toxins-11-00034"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Hoefel</surname><given-names>D.</given-names></name><name><surname>Saint</surname><given-names>C.P.</given-names></name><name><surname>Monis</surname><given-names>P.T.</given-names></name><name><surname>Jin</surname><given-names>B.</given-names></name></person-group><article-title>The isolation and microbial community analysis of hydrogen producing bacteria from activated sludge</article-title><source>J. Appl. Microbiol.</source><year>2007</year><volume>103</volume><fpage>1415</fpage><lpage>1423</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2007.03370.x</pub-id><pub-id pub-id-type="pmid">17953552</pub-id></element-citation></ref><ref id="B108-toxins-11-00034"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallet</surname><given-names>C.</given-names></name><name><surname>Basset</surname><given-names>M.</given-names></name><name><surname>Fonty</surname><given-names>G.</given-names></name><name><surname>Desvilettes</surname><given-names>C.</given-names></name><name><surname>Bourdier</surname><given-names>G.</given-names></name><name><surname>Debroas</surname><given-names>D.</given-names></name></person-group><article-title>Microbial population dynamics in the sediments of a eutrophic lake (Aydat, France) and characterization of some heterotrophic bacterial isolates</article-title><source>Microb. Ecol.</source><year>2004</year><volume>48</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s00248-003-2017-4</pub-id><?supplied-pmid 15085301?><pub-id pub-id-type="pmid">15085301</pub-id></element-citation></ref><ref id="B109-toxins-11-00034"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigand</surname><given-names>M.R.</given-names></name><name><surname>Pena-Gonzalez</surname><given-names>A.</given-names></name><name><surname>Shirey</surname><given-names>T.B.</given-names></name><name><surname>Broeker</surname><given-names>R.G.</given-names></name><name><surname>Ishaq</surname><given-names>M.K.</given-names></name><name><surname>Konstantinidis</surname><given-names>K.T.</given-names></name><name><surname>Raphael</surname><given-names>B.H.</given-names></name></person-group><article-title>Implications of Genome-Based Discrimination between Clostridium botulinum Group I and <italic>Clostridium sporogenes</italic> Strains for Bacterial Taxonomy</article-title><source>Appl. Environ. Microbiol.</source><year>2015</year><volume>81</volume><fpage>5420</fpage><lpage>5429</lpage><pub-id pub-id-type="doi">10.1128/AEM.01159-15</pub-id><?supplied-pmid 26048939?><pub-id pub-id-type="pmid">26048939</pub-id></element-citation></ref><ref id="B110-toxins-11-00034"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Okado</surname><given-names>I.</given-names></name><name><surname>Nakashio</surname><given-names>S.</given-names></name><name><surname>Nishida</surname><given-names>S.</given-names></name></person-group><article-title><italic>Clostridium sporogenes</italic> isolates and their relationship to <italic>C. botulinum</italic> based on deoxyribonucleic acid reassociation</article-title><source>J. Gen. Microbiol.</source><year>1977</year><volume>100</volume><fpage>395</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1099/00221287-100-2-395</pub-id><?supplied-pmid 330814?><pub-id pub-id-type="pmid">330814</pub-id></element-citation></ref><ref id="B111-toxins-11-00034"><label>111.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Drouin</surname><given-names>P.</given-names></name><name><surname>Lafreni&#x000e8;re</surname><given-names>C.</given-names></name></person-group><article-title>Clostridial spores in animal feeds and milk</article-title><source>Milk Production</source><person-group person-group-type="editor"><name><surname>Chaiyabutr</surname><given-names>N.</given-names></name></person-group><publisher-name>IntechOpen</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2012</year><pub-id pub-id-type="doi">10.5772/50775</pub-id></element-citation></ref><ref id="B112-toxins-11-00034"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>R.R.</given-names><suffix>3rd</suffix></name><name><surname>Schill</surname><given-names>K.M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pombert</surname><given-names>J.F.</given-names></name></person-group><article-title>Genetic Characterization of the Exceptionally High Heat Resistance of the Non-toxic Surrogate <italic>Clostridium sporogenes</italic> PA 3679</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>545</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00545</pub-id><pub-id pub-id-type="pmid">28421047</pub-id></element-citation></ref><ref id="B113-toxins-11-00034"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>R.H.</given-names></name><name><surname>Dunn</surname><given-names>M.L.</given-names></name><name><surname>Ogden</surname><given-names>L.V.</given-names></name><name><surname>Jefferies</surname><given-names>L.K.</given-names></name><name><surname>Eggett</surname><given-names>D.L.</given-names></name><name><surname>Steele</surname><given-names>F.M.</given-names></name></person-group><article-title>Conditions associated with Clostridium sporogenes growth as a surrogate for <italic>Clostridium botulinum</italic> in nonthermally processed canned butter</article-title><source>J. Dairy Sci.</source><year>2013</year><volume>96</volume><fpage>2754</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.3168/jds.2012-6209</pub-id><pub-id pub-id-type="pmid">23453518</pub-id></element-citation></ref><ref id="B114-toxins-11-00034"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahn</surname><given-names>R.</given-names></name><name><surname>Scheller</surname><given-names>R.H.</given-names></name></person-group><article-title>SNAREs&#x02014;engines for membrane fusion</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2006</year><volume>7</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/nrm2002</pub-id><?supplied-pmid 16912714?><pub-id pub-id-type="pmid">16912714</pub-id></element-citation></ref><ref id="B115-toxins-11-00034"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubalek</surname><given-names>Z.</given-names></name><name><surname>Halouzka</surname><given-names>J.</given-names></name></person-group><article-title>Persistence of <italic>Clostridium botulinum</italic> type C toxin in blow fly (Calliphoridae) larvae as a possible cause of avian botulism in spring</article-title><source>J. Wildl. Dis.</source><year>1991</year><volume>27</volume><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.7589/0090-3558-27.1.81</pub-id><pub-id pub-id-type="pmid">2023331</pub-id></element-citation></ref><ref id="B116-toxins-11-00034"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anza</surname><given-names>I.</given-names></name><name><surname>Vidal</surname><given-names>D.</given-names></name><name><surname>Feliu</surname><given-names>J.</given-names></name><name><surname>Crespo</surname><given-names>E.</given-names></name><name><surname>Mateo</surname><given-names>R.</given-names></name></person-group><article-title>Differences in the Vulnerability of Waterbird Species to Botulism Outbreaks in Mediterranean Wetlands: An Assessment of Ecological and Physiological Factors</article-title><source>Appl. Environ. Microbiol.</source><year>2016</year><volume>82</volume><fpage>3092</fpage><lpage>3099</lpage><pub-id pub-id-type="doi">10.1128/AEM.00119-16</pub-id><pub-id pub-id-type="pmid">27016572</pub-id></element-citation></ref><ref id="B117-toxins-11-00034"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulain</surname><given-names>B.</given-names></name><name><surname>Tauc</surname><given-names>L.</given-names></name><name><surname>Maisey</surname><given-names>E.A.</given-names></name><name><surname>Wadsworth</surname><given-names>J.D.</given-names></name><name><surname>Mohan</surname><given-names>P.M.</given-names></name><name><surname>Dolly</surname><given-names>J.O.</given-names></name></person-group><article-title>Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1988</year><volume>85</volume><fpage>4090</fpage><lpage>4094</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.11.4090</pub-id><pub-id pub-id-type="pmid">2897693</pub-id></element-citation></ref><ref id="B118-toxins-11-00034"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janz</surname><given-names>R.</given-names></name><name><surname>S&#x000fc;dhof</surname><given-names>T.C.</given-names></name></person-group><article-title>SV2C is a synaptic vesicle protein with an unusually restricted localization: Anatomy of a synaptic vesicle protein family</article-title><source>Neuroscience</source><year>1999</year><volume>94</volume><fpage>1279</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(99)00370-X</pub-id><pub-id pub-id-type="pmid">10625067</pub-id></element-citation></ref><ref id="B119-toxins-11-00034"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montecucco</surname><given-names>C.</given-names></name><name><surname>Rasotto</surname><given-names>M.B.</given-names></name></person-group><article-title>On botulinum neurotoxin variability</article-title><source>MBio</source><year>2015</year><volume>6</volume><pub-id pub-id-type="doi">10.1128/mBio.02131-14</pub-id><?supplied-pmid 25564463?><pub-id pub-id-type="pmid">25564463</pub-id></element-citation></ref><ref id="B120-toxins-11-00034"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nevas</surname><given-names>M.</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>M.</given-names></name><name><surname>Hielm</surname><given-names>S.</given-names></name><name><surname>Bj&#x000f6;rkroth</surname><given-names>K.J.</given-names></name><name><surname>Peck</surname><given-names>M.W.</given-names></name><name><surname>Korkeala</surname><given-names>H.</given-names></name></person-group><article-title>Diversity of proteolytic <italic>Clostridium botulinum</italic> strains, determined by a pulse-field gel electrophoresis approach</article-title><source>Appl. Environ. Microbiol.</source><year>2005</year><volume>71</volume><fpage>1311</fpage><lpage>1317</lpage><pub-id pub-id-type="doi">10.1128/AEM.71.3.1311-1317.2005</pub-id><?supplied-pmid 15746333?><pub-id pub-id-type="pmid">15746333</pub-id></element-citation></ref><ref id="B121-toxins-11-00034"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>M.W.</given-names></name></person-group><article-title>Biology and genomic analysis of Clostridium botulinum</article-title><source>Adv. Microb. Physiol.</source><year>2009</year><volume>55</volume><fpage>183</fpage><lpage>320</lpage><page-range>183&#x02013;265, 320</page-range><?supplied-pmid 19573697?><pub-id pub-id-type="pmid">19573697</pub-id></element-citation></ref><ref id="B122-toxins-11-00034"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erbguth</surname><given-names>F.J.</given-names></name></person-group><article-title>From poison to remedy: The chequered history of botulinum toxin</article-title><source>J. Neural Transm.</source><year>2008</year><volume>115</volume><fpage>559</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s00702-007-0728-2</pub-id><?supplied-pmid 17458494?><pub-id pub-id-type="pmid">17458494</pub-id></element-citation></ref><ref id="B123-toxins-11-00034"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erbguth</surname><given-names>F.J.</given-names></name><name><surname>Naumann</surname><given-names>M.</given-names></name></person-group><article-title>Historical aspects of botulinum toxin. Justinus Kerner (1786&#x02013;1862) and the &#x0201c;sausage poison&#x0201d;</article-title><source>Neurology</source><year>1999</year><volume>53</volume><fpage>1850</fpage><lpage>1853</lpage><pub-id pub-id-type="doi">10.1212/WNL.53.8.1850</pub-id><?supplied-pmid 10563638?><pub-id pub-id-type="pmid">10563638</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="toxins-11-00034-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic summary of the BoNT activity steps.</p></caption><graphic xlink:href="toxins-11-00034-g001"/></fig><table-wrap id="toxins-11-00034-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">toxins-11-00034-t001_Table 1</object-id><label>Table 1</label><caption><p>Botulinum neurotoxin (BoNT) types, subtypes and producer organisms.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Botulinum Toxin Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/A</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BoNT/B</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/E</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">BoNT/F</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/E</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/C</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/D</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/G</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/H</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">BoNT/Ba<break/>BoNT/Bf<break/>BoNT/Ab<break/>BoNT/Af<break/>BoNT/A(B)<break/>BoNT/A2F4F5</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subtypes</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A1, A2, A3, A4, A5, A6, A7, A8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B1, B2, B3, B5, B6, B7, B8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B4</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E1, E2, E3, E6, E7, E8, E9, E10, E11, E12</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F6</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F2, F2, F3, F4, F5, F8</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">F7</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">E4, E5</th><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">C/D, D/C</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H or F/A or H/A</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzymatic substrate<break/>(cleavage site)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNAP25<break/>(QR)</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">VAMP1, 2, 3<break/>(QF)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNAP25<break/>(RI)</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">VAMP1, 2, 3<break/>(QK)<break/>F5: VAMP2 (LE)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP2<break/>(QK)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNAP25<break/>(RI)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SNAP25<break/>(RA)<break/>Syntaxin<break/>(KA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP1, 2, 3<break/>(KL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP1, 2, 3<break/>(AA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP1, 2, 3<break/>(LE)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotoxin-producing bacteria</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic>C. botulinum</italic>
</td><td colspan="3" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic>C. botulinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. botulinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. baratii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. butyricum</italic>
</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
<italic>C. botulinum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>C. argentinense</italic>
</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic>C. botulinum</italic><break/>bivalent/trivalent strains</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Group I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group II</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group II</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group II</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group VI</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Group III</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Group IV</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Group I</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Botulism</td><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Human<break/>Occasionally animal</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Human<break/>Animal not reported</td><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Animal<break/>Very rare in human</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No natural case reported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human</td></tr></tbody></table></table-wrap><table-wrap id="toxins-11-00034-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">toxins-11-00034-t002_Table 2</object-id><label>Table 2</label><caption><p>Putative novel botulinum neurotoxin (BoNT) types and producer organisms.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Botulinum Toxin Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/X</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/I or BoNT/Wo</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BoNT/J<break/>or eBoNT/J<break/>or BoNT/En</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cp1 Toxin<break/>(BoNT Homolog)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Subtypes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bivalent<break/>BoNT/B2-BoNT/X</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzymatic substrate (cleavage site)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP1, 2, 3, 4, 5<break/>Ypkt6<break/>(RA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP2<break/>(WW)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VAMP2<break/>(DL)<break/>SNAP25, 23<break/>(KD)<break/>syntaxin (MD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neurotoxin-producing bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. botulinum</italic> strain 111<break/>group I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Weisella oryzae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Enterococcus faecium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Chryseobacterium piperi</italic>
</td></tr></tbody></table><table-wrap-foot><fn><p>The putative novel BoNTs have not been reported to be responsible for human or animal botulism.</p></fn></table-wrap-foot></table-wrap><table-wrap id="toxins-11-00034-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">toxins-11-00034-t003_Table 3</object-id><label>Table 3</label><caption><p>Binding affinity to receptor of Botulinum neurotoxins (BoNT) and representative potent lethal bacterial toxins.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Toxin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Neuronal Membrane/Receptors</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">K<sub>d</sub> Affinity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BoNT/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SV2C, neurons</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.46 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-toxins-11-00034" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BoNT/B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat synaptotagmin/GT1b, rat brain synaptosomes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02248;0.4 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-toxins-11-00034" ref-type="bibr">59</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BoNT/B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mouse synaptotagmin II<break/>Human synatotagmin II</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">130 nM<break/>&#x0003e;20 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-toxins-11-00034" ref-type="bibr">60</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diphtheria toxin (DT)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heparin Binding-EGF</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.3 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-toxins-11-00034" ref-type="bibr">61</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diphtheria toxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LCH cells (L cells expressing DT receptor)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-toxins-11-00034" ref-type="bibr">62</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Protective antigen <italic>Bacillus anthrax</italic> toxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Capillary morphogenesis protein 2 (CMG2)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.17 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-toxins-11-00034" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anthrax toxin receptor/tumor endothelial marker 8 (ATR/TEM8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">130 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-toxins-11-00034" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Clostridium perfringens</italic> epsilon toxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat brain synaptosome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.5 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-toxins-11-00034" ref-type="bibr">65</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Clostridium sordellii</italic> lethal toxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Porcine brain phosphatidyl serine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">140 nM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-toxins-11-00034" ref-type="bibr">66</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>